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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and provide for the safety of workers 
exposed to an ever-increasing number of potential hazards at their 
workplace. The National Institute for Occupational Safety and Health has 
projected a formal system of research, with priorities determined on the 
basis of specified indices, to provide relevant data from which valid 
criteria for effective standards can be derived. Recommended standards for 
occupational exposure, which are the result of this work, are based on the 
health effects of exposure. The Secretary of Labor will weigh these 
recommendations along with other considerations such as feasibility and 
means of implementation in developing regulatory standards.
It is intended to present successive reports as research and 
epidemiologic studies are completed and as sampling and analytical methods 
are developed. Criteria and standards will be reviewed periodically to 
ensure continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
vanadium by members of the NIOSH staff and the valuable constructive 
comments by the Review Consultants on vanadium, by the ad hoc committees of 
the American Academy of Industrial Hygiene, and the American Occupational 
Medical Association, and by Robert B. O'Connor, M.D., NIOSH consultant in
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occupational medicine. The NIOSH recommendations for standards are not 
necessarily a consensus of all the consultants and professional societies 
that reviewed this criteria document on vanadium. A list of Review 
Consultants appears on page v i .
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Director, National Institute for 
Occupational Safety and Health
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Institute for Occupational Safety and Health, had primary responsibility 
for the development of the criteria and recommended standard for vanadium. 
Terence M. Grady of this Division served as criteria manager. SRI 
International developed the basic information for consideration by NIOSH 
staff and consultants under contract CDC-99-74-31.
The Division review of this document was provided by Keith H. Jacobson, 
Ph.D. (Chairman), Frank L. Mitchell, D.O., and Paul E. Caplan, with Herbert 
E. Stokinger, Ph.D. (Division of Biomedical and Behavioral Science), Harry 
M. Donaldson (Division of Surveillance, Hazard Evaluations, and Field 
Studies), and Seymour D. Silver, Ph.D.
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I. RECOMMENDATIONS FOR A VANADIUM STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to vanadium and its compounds in the 
workplace be controlled by adherence to the following sections. The 
standard is designed to protect the health and provide for the safety of 
employees for up to a 10-hour work shift, 40-hour workweek, over a working 
lifetime. Compliance with all sections of the standard should prevent 
adverse effects of vanadium and its compounds on the health of workers and 
provide for their safety. Sufficient technology exists to permit 
compliance with the recommended standard. Although NIOSH considers the 
workplace environmental limit to be a safe level based on current 
information, the employer should regard it as the upper boundary of 
exposure and make every effort to maintain the exposure as low as is 
technically feasible. The standard will be subject to review and revision 
as necessary.
"Vanadium" includes vanadium compounds, metallic vanadium, and 
vanadium carbide. "Vanadium compounds" include all chemically combined 
forms of vanadium but not alloys, intermetallics, or vanadium carbide. 
"Metallic vanadium" includes the element alone or in alloys or inter­
metallics, such as ferrovanadium and vanadium-aluminum. "Occupational 
exposure" to vanadium is defined as exposure to airborne vanadium above the 
action level. An "action level" is defined as equal to the environmental 
limit for that form of vanadium (see Section 1). Exposures to vanadium at 
lower concentrations will not require adherence to the recommended standard 
except for Sections 2(a,e), 3(b), 5(a,c), and 8(a).
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The recommended standard is based on data which indicate that 
vanadium is a primary irritant to the respiratory tract, eyes, and skin. 
The irritation is usually reversible with no known residual systemic 
effects.
Section 1 - Environmental (Workplace Air)
(a) Concentrations
Occupational exposure to vanadium compounds shall be controlled so 
that employees are not exposed at a concentration greater than 0.05 
milligrams of vanadium per cubic meter of air (0.05 mg V/cu m) measured as 
a ceiling concentration during any 15-minute sampling period.
Occupational exposure to metallic vanadium and vanadium carbide shall 
be controlled so that employees are not exposed at a concentration greater 
than 1.0 mg of vanadium/cu m measured as a time-weighted average (TWA) 
concentration for up to a 10-hour workday, 40-hour workweek, over a working 
lifetime.
(b) Sampling and Analysis
Environmental samples shall be collected and analyzed as described in 
Appendices I and II, or by any methods at least equivalent in accuracy, 
precision, and sensitivity.
Section 2 - Medical
Medical surveillance shall be made available as outlined below to all 
persons subject to occupational exposure to vanadium.
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(a) Preplacement medical examinations shall include as a minimum:
(1) Comprehensive medical and work histories with special 
emphasis directed to evidence of chronic eye or skin disorders and 
respiratory conditions or allergies.
(2) Physical examination giving particular attention to the 
upper respiratory tract and eyes.
(3) Specific clinical tests including at least:
(A) A 14- x 17-inch posteroanterior chest
roentgenogram.
(B) Tests of pulmonary function including forced 
expiratory volume during the 1st second (FEV 1) and forced vital capacity 
(FVC) .
(4) A judgment of the worker's ability to use negative or 
positive pressure respirators.
(b) Periodic examination shall be made available at least 
annually, except as otherwise determined by the responsible physician, as 
follows:
(1) Interim medical and work histories.
(2) Physical examination as outlined in paragraph (a)(2) of
this section.
(3) Pulmonary function tests as outlined in (a)(3)(B). A 
chest X-ray shall be taken at the discretion of the responsible physician, 
based on knowledge of work exposure and clinical findings.
(c) During examinations, applicants or employees found to have 
medical conditions, such as chronic upper or lower respiratory irritation, 
that could be directly or indirectly aggravated by exposure to vanadium
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shall be counseled as to the possibly increased risk of impairment of their 
health from working with the substances.
(d) Initial medical examinations shall be made available to all 
employees within 6 months of the promulgation of a standard based on these 
recommendations.
(e) Pertinent medical records shall be kept for at least 30 years 
after employment has ended for all employees exposed to vanadium in the 
workplace. These records shall be made available to the designated medical 
representatives of the Secretary of Health, Education, and Welfare, of the 
Secretary of Labor, of the employer, and of the employee or former 
employee.
Section 3 - Labeling and Posting
(a) All labels and warning signs shall be printed both in English 
and in the predominant language of non-English-reading workers. Illiterate 
workers and workers reading languages other than those used on labels and 
posted signs shall receive information regarding hazardous areas and shall 
be informed of the instructions printed on labels and signs. Recommended 
labels and signs apply to all forms of vanadium except solid metallic 
forms, such as ingots, sheets, rods, and bars.
(b) Containers of vanadium shall carry a label which bears the 
chemical name of the compound contained therein and information on the 
effects of the particular compound on human health. The name and pertinent 
information shall be arranged as in the example below:
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(CHEMICAL NAME)
HARMFUL IF INHALED OR SWALLOWED 
IRRITATING TO SKIN AND EYES
Avoid contact with eyes, skin, and clothing.
Keep container closed.
Use only with adequate ventilation.
First A i d : In case of skin or eye contact, flush immediately
and thoroughly with running water and consult a physician. If 
swallowed, consult a physician.
(c) In areas where vanadium is used, a sign containing information 
on the effects of the specific compound on human health shall be posted in 
readily visible locations. This information shall be arranged as in the 
example below:
(CHEMICAL NAME)
HARMFUL IF INHALED OR SWALLOWED 
IRRITATING TO SKIN AND EYES
Avoid inhaling vapor, dust, or fume.
Avoid contact with skin, eyes, mouth, and clothing.
Provide adequate ventilation.
First A i d : In case of skin or eye contact, flush immediately
and thoroughly with running water and consult a physician. If 
swallowed, consult physician.
(d) If respirators are required, the following statement shall be 
added in large letters to the sign required in Section 3(b):
RESPIRATORY PROTECTION REQUIRED IN THIS AREA
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Section 4 - Personal Protective Equipment and Clothing
The employer shall use engineering controls if needed to keep the 
concentration of airborne vanadium at or below the limits specified in 
Section (l)(a) and shall provide protective clothing and equipment 
resistant to the penetration of vanadium when necessary to prevent gross 
skin and eye contact with liquid vanadium compounds or vanadium solutions. 
Protective equipment suitable for emergency use shall be located at clearly 
identified stations outside the work area.
(a) Protective Clothing
(1) The employer shall provide chemical safety goggles or 
face shields (8-inch minimum) with goggles and shall ensure that employees 
wear the protective equipment during any operation in which vanadium may 
enter the eyes.
(2) The employer shall provide appropriate clothing and 
equipment, including gloves, aprons, suits, boots, or face shields and 
goggles, and shall ensure that employees wear these where needed to prevent 
gross skin and eye contact.
(b) Respiratory Protection
Engineering controls shall be used when needed to maintain airborne 
vanadium concentrations at or below the recommended environmental limits. 
Compliance with the permissible exposure limits by the use of respirators 
is permitted only during installation and testing of engineering controls, 
during performance of nonroutine maintenance or repair, when working in 
confined spaces, or during emergencies. When use of a respirator is 
permitted, it shall be selected and used in accordance with the following 
requirements:
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(1) To determine the type of respirator to be used, the
employer shall measure the concentrations of airborne vanadium in the 
workplace initially and thereafter whenever control, process, operation, 
worksite, or climatic changes occur that are likely to increase the 
concentration of airborne vanadium.
(2) The employer shall ensure that no employee is exposed
to vanadium above the recommended limits because of improper respirator 
selection, fit, use, or maintenance.
(3) A respiratory protection program meeting the 
requirements of 29 CFR 1910.134 that incorporates the American National 
Standard Practices for Respiratory Protection, Z88.2-1969, shall be 
established and enforced by the employer.
(4) The employer shall provide respirators in accordance
with Tables 1-1 and 1-2 and shall ensure that the employees properly use
the respirators provided when wearing respirators is required. The 
respiratory protective devices provided in conformance with Tables 1-1 and 
1-2 shall be those approved by NIOSH and the Mining Enforcement and Safety 
Administration (MESA) as specified under the provisions of 30 CFR 11.
(5) Respirators specified for use in higher concentrations 
of airborne vanadium may be used in atmospheres with lower concentrations.
(6) The employer shall ensure that employees are properly
instructed in the use of respirators assigned to them and on how to test 
for leakage, proper fit, and proper operation.
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TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR VANADIUM COMPOUNDS
Concentration
Respirator Type Approved 
under Provisions of 30 CFR 11
Less than or 
equal to 0.5 mg/cu m
(1) High-efficiency particulate fil­
ter respirator with full facepiece
(2) Supplied-air respirator with full 
facepiece, helmet, or hood
(3) Self-contained breathing appara­
tus with full facepiece
Less than or 
equal to 70 mg/cu m
(1) Powered air-purifying respirator 
with full facepiece and high-efficien­
cy particulate filter
(2) Type C supplied-air respirator 
with full facepiece operated in pres- 
sure-demand or other positive pressure 
mode or with full facepiece, helmet, 
or hood operated in continuous-flow 
mode
Greater than 
70 mg/cu m  or 
emergency entry 
(into area of 
unknown concentration)
(1) Self-contained breathing appara­
tus with full facepiece operated in 
pressure-demand or other positive 
pressure mode
(2) Combination respirator that in­
cludes Type C supplied-air respirator 
with full facepiece operated in pres­
sure-demand or other positive pressure 
or continuous-flow mode and auxiliary 
self-contained breathing apparatus op­
erated in pressure-demand or other 
positive pressure mode
Firefighting Self-contained breathing apparatus 
with full facepiece operated in pres­




RESPIRATOR SELECTION GUIDE FOR METALLIC VANADIUM AND VANADIUM CARBIDE
Concentration
Respirator Type Approved 
under Provisions of 30 CFR 11
Less than or 
equal to 5 mg/cu m
Dust and mist respirator except single­
use type
Less than or 
equal to 10 mg/cu m
(1) Dust and mist respirator except 
single-use or quarter-mask type
(2) Supplied-air respirator
(3) Self-contained breathing apparatus
Less than or 
equal to 50 mg/cu m
(1) High-efficiency particulate filter 
respirator with full facepiece
(2) Supplied-air respirator with full 
facepiece, helmet, or hood
(3) Self-contained breathing apparatus 
with full facepiece
Less than or 
equal to 500 mg/cu m
(1) Powered air-purifying respirator with 
full facepiece and high-efficiency parti­
culate filter
(2) Type C supplied-air respirator with 
full facepiece operated in pressure-demand 
or other positive pressure mode or with 
full facepiece, helmet, or hood operated in 
continuous-flow mode
Greater than 
500 mg/cu m or 
emergency entry 
(into area of 
unknown concentration)
(1) Self-contained breathing apparatus 
with full facepiece operated in pressure- 
demand or other positive pressure mode
(2) Combination respirator that includes 
Type C supplied-air respirator with full 
facepiece operated in pressure-demand or 
other positive pressure or continuous- 
flow mode and auxiliary self-contained 
breathing apparatus operated in pressure- 
demand or other positive pressure mode
Firefighting Self-contained breathing apparatus with 
full facepiece operated in pressure-demand 
or other positive pressure mode
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(7) The employer shall establish and conduct a program of 
cleaning, sanitizing, inspecting, maintaining, repairing, and storing of 
respirators to ensure that employees are provided with clean respirators 
that are in good operating condition.
(8) The employer shall periodically monitor the use of 
respirators to ensure that the proper type of respirator is worn, to 
evaluate the effectiveness of the respiratory protection program, and to 
eliminate any deficiencies in use and care of respirators.
(9) Respirators shall be easily accessible, and employees 
shall be informed of their location.
Section 5 - Informing Employees of Hazards from Vanadium
(a) At the beginning of employment and at least annually
thereafter, the employer shall provide information to employees subject to 
occupational exposure to vanadium.
(b) The employer shall institute a continuing education program,
conducted by persons qualified by experience or training, to ensure that
all employees have current knowledge of job hazards, proper maintenance and 
cleanup methods, and proper respirator usage. The instructional program 
shall include a description of the general nature of the environmental and 
medical surveillance procedures and of the advantages to the employee of 
participating in these surveillance procedures. As a minimum, instruction 
shall include the information in Appendix III, which shall be kept on file, 
and it shall be readily accessible to employees at all places of employment 
where exposure may occur.
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(c) Required information shall be recorded on the "Material Safety
Data Sheet" shown in Appendix III or on a similar form approved by the
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Control of Airborne Vanadium
Engineering controls, such as ^process enclosure or local exhaust 
ventilation, shall be used when needed to keep exposures to vanadium 
concentrations within the recommended environmental limits. Ventilation 
systems, if used, shall be designed to prevent the accumulation of vanadium
in the workplace environment and to effectively remove vanadium from the
breathing zone of employees. Exhaust ventilation systems discharging to 
outside air must conform with applicable local, state, and federal air 
pollution regulations and must not constitute a hazard to employees. 
Ventilation systems shall be subject to regular preventive maintenance and 
cleaning to ensure effectiveness, which shall be verified by airflow
measurements taken at least every 3 months.
(b) Storage
Containers of vanadium shall be kept tightly closed at all times when 
not in use. Containers shall be stored in a safe manner to minimize 
accidental breakage, spillage, or contact with moisture. Combustible 
materials, such as finely ground vanadium carbide, vanadium-aluminum 




(c) Handling and General Work Practices
(1) Before maintenance work is undertaken, sources of 
vanadium shall be shut off. If respiratory protection is needed, see 
Section 4 for appropriate direction.
(2) Employees who have gross skin contact with vanadium, 
excluding vanadium ores, shall wash or shower, if necessary, to remove 
vanadium from the skin. Contaminated clothing shall be removed and 
discarded or cleaned before reuse. Prior to cleaning, contaminated 
clothing for reuse shall be stored in a container which is impervious to 
the compound. Personnel involved in cleaning contaminated clothing shall 
be informed of the hazards involved and be provided with safety guidelines 
on the handling of these compounds.
Section 7 - Sanitation
(a) The preparation, storage, or consumption of food should not be
allowed in vanadium work areas.
(b) Employees who handle vanadium or equipment contaminated with 
vanadium should be advised to wash their hands thoroughly with soap or mild 
detergent and water before eating, smoking, or using toilet facilities.
(c) Waste material contaminated with vanadium shall be disposed of
in a manner not hazardous to employees. The disposal method must conform 
with applicable local, state, and federal regulations and must not 
constitute a hazard to the surrounding population or environment.
12
Section 8 - Environmental Monitoring and Recordkeeping
(a) Industrial Hygiene Surveys
Within 6 months of the promulgation of a standard based on these 
recommendations, employers shall conduct an industrial hygiene survey at 
locations where there is vanadium in the workplace air to determine if 
there is exposure to airborne vanadium at concentrations greater than the 
limits recommended in Section 1 (a). Records of these surveys, including 
the basis for concluding that concentrations of airborne vanadium are at or 
below the action level, shall be maintained. Surveys shall be repeated at 
least annually and within 30 days of any change likely to result in 
increased concentrations of airborne vanadium.
(b) Personal Monitoring
If it has been determined that the environmental concentration of 
vanadium exceeds the action level, then the employer shall fulfill the 
following requirements:
(1) A program of personal monitoring shall be instituted to 
identify and measure, or permit calculation of, the exposure of each 
employee occupationally exposed to vanadium. Source and area monitoring 
may be used to supplement personal monitoring.
(2) In all personal monitoring, samples representative of 
the exposure in the breathing zone of the employee shall be collected.
(3) For each determination of the TWA or ceiling 
concentration, a sufficient number of samples shall be taken to 
characterize employee exposure. Variations in the employee's work 
schedule, location, or duties and changes in production schedules shall be 
considered in deciding when samples are to be collected.
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(4) Each operation in each work area shall be sampled at
least once every 6 months or as otherwise indicated by a professional
industrial hygienist. If an employee is found to be exposed to vanadium at 
concentrations above the limits recommended in Section 1(a), the exposure 
of that employee shall be measured at least once every week, control
measures necessary to reduce the concentration of vanadium in the
employee's environment to less than or equal to the limits recommended in 
Section 1(a) shall be initiated, and the employee shall be notified of the 
exposure and of the control measures being implemented. Such monitoring 
shall continue until two consecutive determinations, at least 1 week apart, 
indicate that the employee's exposure no longer exceeds the recommended 
environmental limits. At that point, semiannual monitoring may be resumed.
(c) Recordkeeping
Environmental monitoring records shall be maintained for at least 30 
years. These records shall include the name of the employee being 
monitored, duties performed and job locations within the worksite, dates of 
measurements, sampling and analytical methods used, the number, duration, 
and results of samples taken, TWA and ceiling concentrations estimated from 
these samples, and the type of personal protection used, if any, by the 
employee. Employees shall be able to obtain information on their own 
environmental exposures. Environmental records shall be made available to 
designated representatives of the Secretary of Labor and of the Secretary 
of Health, Education, and Welfare.
Pertinent medical records shall be retained for 30 years after the 
last occupational exposure to vanadium. Records of environmental exposures 
applicable to an employee should be included in that employee's medical
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records. These medical records shall be made available to the designated 
medical representatives of the Secretary of Labor, of the Secretary of 
Health, Education, and Welfare, of the employer, and of the employee or 
former employee.
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I I . INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing impairment of 
health from exposure to vanadium and its compounds. The criteria document 
fulfills the responsibility of the Secretary of Health, Education, and 
Welfare under Section 20(a)(3) of the Occupational Safety and Health Act of 
1970 to "...develop criteria dealing with toxic materials and harmful 
physical agents and substances which will describe...exposure levels at 
which no employee will suffer impaired health or functional capacities or 
diminished life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health and to provide for the safety of employees exposed to 
hazardous chemical and physical agents. The criteria and recommended 
standard should enable management and labor to develop better engineering 
controls resulting in more healthful work environments and simply complying 
with the recommended standard should not be the final goal.
These criteria for a standard for vanadium and its compounds are part 
of a continuing series of criteria developed by NIOSH. The proposed 
standard applies to the processing, manufacture, use of, or other 
occupational exposure to vanadium and its compounds as applicable under the 
Occupational Safety and Health Act of 1970. The standard was not designed 
for the population-at-large, and any extrapolation beyond occupational 
exposures is not warranted. It is intended to (1) protect against injury
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from vanadium and its compounds, (2) be measurable by techniques that are 
valid, reproducible, and available to industry and government agencies, and
(3) be attainable with existing technology.
Occupational exposure to vanadium presents an inhalation hazard, 
primarily respiratory tract irritation, with possible eye and skin 
irritation. Although comparative toxicities of various vanadium compounds 
have not been completely defined, it appears that ferrovanadium and other 
metallic forms of vanadium do not present as severe an occupational hazard.
Significant research needs include more information on toxicities of, 
sampling and analysis of, and preventive procedures for volatile vanadium 
compounds such as vanadium oxytrichloride.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Vanadium is a chemical element that occurs in ores at about 0.02% of 
the earth's crust. It may occur in oxidation states of 0, II, III, IV, and 
V in such compounds as those that appear in Table XII-1 [1]. After 
refining, it is a light gray, malleable, ductile metal that is hardened and 
embrittled after reaction with oxygen, nitrogen, or hydrogen. Chemical and 
physical properties of vanadium and its industrially important compounds, 
primarily pentavalent, are presented in Table XII-1. It is found in air, 
food, plants, and animals. While some evidence suggests that vanadium may 
be an essential trace element for mammals, the issue has not been resolved.
Occupational exposure to vanadium-containing dusts is encountered in 
the mining of vanadium-bearing ores. Most of the vanadium-bearing ores in 
the United States come from Arkansas, Colorado,, and Idaho while foreign 
sources include South Africa, Chile, and the USSR [2]. In milling, 
exposure to vanadium-containing dust can occur near the production sites of 
numerous vanadium compounds, particularly vanadium pentoxide and, to a 
lesser extent, the vanadates. Numerous exposures to vanadium compounds 
have occurred during the cleaning of oil-fired burners, where the dust is 
generated from the residual oil ash of high-vanadium content oil. 
Occupations with potential exposure to vanadium and its compounds as 
presented by Gafafer [3] are listed in Table XII-2.
Vanadium production in the world and US production, consumption, 
exports, and imports are shown in Table III-l [4], expressed in short tons 
(1 short ton=2,000 lb).
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TABLE III-l
VANADIUM PRODUCTION IN WORLD AND US PRODUCTION, CONSUMPTION, 
EXPORTS, AND IMPORTS (SHORT TONS)
Variable 1971 1972 1973 1974 1975
World production 20,502 20,239 21,653 21,112 23,831
United States
Production
Recoverable vanadium*, ore 
and concentrate
5,252 4,887 4,377 4,870 4,743
Vanadium oxides recovered**, 
ore and concentrate
5,293 5,248 4,864 5,368 4,859
Consumption 4,802 5,227 6,393 7,200 5,501
Exports
Ferrovanadium and other 
vanadium alloying materials, 
gross weight
676 269- 1,416 1,335 1,018
Vanadium ores, concentrates, 
oxides, and vanadates
260 176 232 203 215
General imports
Ferrovanadium, gross weight 89 578 303 225 179
Ores, slags, and residues 2,350 1,400 2,600 2,485 2,895
Vanadium pentoxide (anhydride) 30 _*** - • k - k - k 533 1,275
*Recoverable vanadium contained in uranium and vanadium ores and concen­
trates received at mills, plus vanadium recovered from ferrophosphorus 
derived from domestic phosphate rock
**Produced directly from all domestic sources; includes metavanadates; 
figure for 1971 also includes small byproduct quantities from imported 
chromium ores.
***Less than 1/2 short ton
Adapted from reference 4
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Consumption by type of material in the US for 1975 included 4,703 
short tons as ferrovanadium, 216 short tons as vanadium oxides, 26 short 
tons as ammonium metavanadate, and 556 short tons as other vanadium 
compounds [4]. Domestic consumption of vanadium by end use was as follows: 
30% in vanadium-bearing steel and iron products (as alloying agent); 30% in 
the transportation industry as titanium-based alloys, steel, and cast iron; 
10% in construction machinery and industrial equipment; 10% in metal 
working machinery and tools (total for alloy use is 80%); 5% in chemical 
and allied products, eg, catalysts; and 15% miscellaneous use. One of the
most important catalytic uses of vanadium is in the oxidation of sulfur
dioxide to sulfur trioxide in the preparation of sulfuric acid. Vanadium 
oxytrichloride is used as a catalyst in the production of ethylene- 
propylene synthetic rubber. Uses of vanadium compounds are numerous, but 
the quantity used by the chemical and related industries has been small 
compared with metallurgical applications.
NIOSH estimates that approximately 174,000 employees in the United 
States have potential exposure to vanadium and its compounds.
Historical Reports
Vanadium was discovered by Sefstrom in 1830 and was named after 
Vanadis, a Scandinavian goddess [5]. The first commercial use for vanadium 
developed about 1860, when vanadium salts were used as coloring agents [2]. 
Its use as an alloying element in steels was begun about 1905 by the US 
automobile industry, primarily the Ford Motor Company. However, its
beneficial effects in certain special steels were recognized in Europe as
early as 1896. The manufacture of specialty steels has continued to be an
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important market for vanadium. Although its catalytic properties were 
recognized and used as early as 1870, this application, while important, 
has remained small. Since 1960, the use of vanadium in nonferrous alloys, 
principally titanium alloys, for jet engines and airframes has become 
increasingly important.
Experimental studies using vanadium, begun in the 1870's, are 
depicted in the following paragraphs.
In 1876, Priestly [6] studied the toxicity of sodium metavanadate 
solution injected into the veins, alimentary canal, or subcutaneous tissue 
of frogs, pigeons, guinea pigs, rabbits, cats, and dogs. The lethal dose 
of vanadium pentoxide injected subcutaneously into rabbits ranged from 9.18 
to 14.66 mg/kg. The author noted that there were two chief modes of 
action: a central effect on the nervous system causing drowsiness and
convulsions, followed by gradual paralysis of both respiration and body 
motion, and an effect on the alimentary tract causing diarrhea and bloody 
stools. He reported a slowing and weakening of heart action accompanied by 
intermittent decreases in blood pressure, each decrease followed by partial 
recovery; this was thought to be a result of an effect on the vasomotor 
center of the central nervous system (CNS) and intracardiac nerve 
mechanisms.
In 1877, Gamgee and Larmuth [7] and Larmuth [8], from experiments 
with sodium metavanadate (NaV03), pyrovanadate (Na4V207), and orthovanadate 
(Na3V04), concluded that vanadium acted similarly to digitalis; however, 
they noted that the "intracardiac nervous mechanism" was affected in some 
way that did not exactly correspond to the effects of digitalis. In the 
frog, they observed that the heart ventricles became contracted from the
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action of vanadium but that vagus stimulation did not cause a dilatation. 
During perfusion, the ventricles became permanently contracted while the 
atria were still beating. Experiments with white rats showed that 
injections of sodium pyrovanadate caused death more readily than injections 
of sodium orthovanadate. The authors [7,8] concluded from both experiments 
that orthovanadate was less harmful to frogs or rats than the metavanadate 
or pyrovanadate.
Dowdeswell [9], in 1878, described an extensive fatty degeneration in 
the livers of dogs and cats administered ammonium metavanadate orally or 
subcutaneously. The author stated that the lethal dose for rabbits, guinea 
pigs, and dogs was about 10 mg/kg of vanadium pentoxide but that it was 
less than 10 mg/kg for cats.
Jackson's experiments [10,11] in 1912 concerned the effects of 
intravenous (iv) injection of 1% sodium orthovanadate on the circulation of 
dogs. There was a rise in blood pressure caused by systemic 
vasoconstriction attributed to a direct action of the orthovanadate on 
arterial muscle or vasomotor ending^. The heartbeat was not strengthened. 
The pressure in the pulmonary artery also rose as a result of systemic and 
pulmonary vasoconstriction. Perfused blood vessels of the lungs were 
constricted. There was evidence of the bronchial muscles having moderate 
but prolonged constriction.
In 1917, Proescher et al [12] investigated the effects of injected 
and orally administered vanadium on humans. Sodium tetravanadate 
(described as Na2V4011) injected iv into a man at a dose of 20 mg caused 
constriction of the throat, salivation, lacrimation, temporary 
disappearance of pulse and respiration, diarrhea, vomiting, and a drop in
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body temperature of 3 degrees. The authors estimated that 30 mg of the 
tetravanadate, injected iv, was a fatal dose for a 70-kg man. Vanadium 
pentoxide at iv or intramuscular (im) doses of 10 mg or at 20 mg (im or 
subcutaneous) caused few problems when injected properly. The safe dose of 
sodium hexavanadate (described as Na4V6015) by an unspecified route was 60 
mg for men and 40 mg for women, while the emetic dose was estimated at 100- 
120 mg. Sodium tetravanadate was administered orally at a daily dose of 
12.5 mg for 12 days to a healthy young man and the total dose was 
completely recovered in the urine (12.4%) and feces (87.6%). This proved 
to the authors that vanadium orally administered was quickly and 
quantitatively eliminated, mainly through the feces.
Levaditi et al [13], in 1928, found that finely pulverized metallic 
vanadium, suspended in olive oil or isotonic glucose solution and injected 
im, had a curative effect on spontaneous spirochetosis and on 
experimentally induced syphilis in rabbits.
In 1939, Pereira [14] injected im a water solution containing 
vanadium sodium tartrate (0.15 g in 2 ml) twice weekly into patients who 
were in the primary stages of syphilis. He reported prompt disappearance 
of spirochetes, secondary lesions, and gummata, none of which was 
responsive to treatment by bismuth, arsenic, and the Salvarsan series. He 
found it also effective in yaws. The toxicity was low; only a few 
occurrences of oral inflammation, erythema, and hepatic reaction were 
observed in rabbits injected at doses of 0.02 g of the tartrate (8 total 
injections) over a few days.
The first description of vanadium poisoning in workers was given by 
Dutton [15] in 1911. The men were primarily exposed to vanadium oxide dust
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and fume. The men had a dry, irritating cough, blood-stained sputum, and 
anemia, preceded by an increased erythrocyte count, pallor, anorexia, 
emaciation, albuminuria and casts, hematuria, tremors, eye irritation, 
vertigo, hysteria, and depression. Dutton found that tuberculosis often 
developed, sometimes causing death. He referred to the therapeutic use of 
vanadium pentoxide in diseases resulting from defective metabolism and to 
the poisoning that sometimes resulted from its administration. Dutton also 
remarked that illness was sometimes caused by wearing clothing dyed by 
vanadium salts.
Hamilton [16], in 1925, reported that she was unable to verify 
Dutton's observations [15] on a visit to a vanadium plant. Physicians 
interviewed at the plant, however, stated that the men always had a cough 
and a physician at a nearby hospital said that the dust caused an 
infiltration of the lungs, with moist rales throughout the chest.
Effects on Humans
Much of the information on effects of vanadium and its compounds on 
humans has come from accidental exposures of workers in vanadium 
manufacturing and processing plants and in boiler cleaning operations. 
Some questions posed by these studies have stimulated experimentation 
involving controlled exposures of humans.
Gul'ko [17], in 1956, reported on the effects of exposure to vanadium 
compounds on seven vanadium plant workers, 19-55 years old, with 1-8 years 
of employment. The plant processes included crushing, grinding, screening, 
loading, and boiling the unspecified technical product to yield ammonium 
metavanadate. Another process involved unloading, grinding, and packing of
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sodium metavanadate. A final process involved grinding, mixing, and 
packing of vanadium pentoxide. Manual procedures and lack of ventilation 
in these areas caused very dusty conditions. Although air sampling by 
membrane filters was conducted at each site, the method of analysis was not 
described. Analysis of the urine for vanadium content in four of the 
workers and in four controls was performed by a phosphotungstate method. 
Chest roentgenograms, general examination (unspecified tests) of the blood 
and urine, and examination of the nose and throat were all conducted.
Mean concentrations of vanadium-bearing dusts ranged from 3.6 mg/cu m 
at the vanadium pentoxide site to 25.1 mg/cu m at the technical product 
grinding area [17], Ninety-five percent of the dust particles of pure 
vanadium pentoxide, ammonium metavanadate, and sodium metavanadate were 
less than 5 n m  in size. Vanadium contents of the dust sampled were not 
reported. Vanadium content in the urine of the four tested workers was 
0.02-0.05 mg/100 ml of urine and was undetectable in the four controls. 
The complaints of the seven workers, exposed for 2-3 months at a time, were 
irritation of the respiratory tract and eyes that included frequent 
sneezing, gagging, coughing, and a feeling of scratchiness in the eyes. 
The mucous lining of the nose was dry, the mucosa of the posterior wall of 
the throat was hyperemic, and, in most workers (number unreported), minor 
nosebleeds were noted. After work hours, the workers felt better. The 
lowest concentration of dust found in the sodium metavanadate and vanadium 
pentoxide areas was 0.5-2.2 mg/cu m. Gul'ko concluded that the minimum 
concentrations in those areas caused respiratory irritation and 
conjunctivitis.
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Because vanadium compounds caused irritation of the respiratory 
tract, Gul'ko [17] recommended that protective equipment be worn while
processing those compounds and that workers have periodic medical
examinations. He also recommended that the threshold limit value (TLV) for 
vanadium dust compounds [18] be lowered to less than 0.5 mg/cu m.
In 1962, Zenz et al [19] studied the effects of vanadium on 18 
pelletizing plant workmen, 21-55 years old, who inhaled pure vanadium 
pentoxide dust at concentrations greater than 0.5 mg/cu m. Purified
vanadium pentoxide was received at the plant as a fine, dry powder in 55- 
gallon metal drums. The powder was dumped into a hopper and then conveyed 
on an open moving belt to a muller where the particles were reduced to a 
smaller size and moistened to assist in pellet formation. The material was 
then conveyed by an open moving belt to a pelletizing pan for conversion to 
pellets. All of these operations depended on open ventilation to remove 
atmospheric contaminants, except for two small vents along the conveyor 
belt. The 24-hour continuous process generated a heavy dust roughly
estimated from cloud density to be 100-500 million particles/cu ft of air
throughout the plant. Dust counts were not taken during this particular 
pelletizing operation but from previous runs of the same ores. Air
concentrations of vanadium pentoxide were believed to be greater than 0.5 
mg/cu m, with a mean particle size of less than 5 jum, although no
measurements were made. Particle sizes ranged from 0.1 to 10 ¿im; however, 
it was later determined by the authors that the sampling filter used for 
this determination was of improper type and incapable of collecting all of 
the vanadium pentoxide particles. Vanadium fume may also have been 
produced from the high-temperature kiln used in the pelletizing process.
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Felt-pad respirators were provided to men working in process areas, 
but other plant employees entered these work areas without respirators 
[19]. Ultrafine filter-type respirators were recommended and air-line 
respirators were provided for men working in the most dusty locations. 
Three of the 18 workmen had not worn their masks and complained after 1 
day's work of dry cough, sore throat, and burning eyes. Medical 
examination of the three workers after 2 additional days' work showed 
conjunctivitis and inflamed throats. The three workers were sent home for 
3 days. They returned to work on the 4th day and wore their respirators, 
only to have their symptoms recur at a greater intensity within 0.5-4 
hours. Moreover, rales were observed throughout the lungs. Incessant 
coughing prevented the workers from using their respirators any further.
The industrial process continued for 2 weeks, and 16 of the 18 
workers examined had conjunctivitis and inflammation of the nose and 
throat, hacking cough, rales, and wheezing [19]. The two remaining workers 
developed only upper respiratory irritation. Bronchospasm in an unreported 
number of seriously affected workers persisted for 48 hours after removal 
from exposure, the rales lasted 3-7 days, but the cough persisted for 2 
weeks in many others. Of the 16 men with lower respiratory tract effects, 
6 showed severe illness, 7 were moderately ill, and 3 had minimal illness. 
Four of the 18 men complained of skin itch and a sensation of heat in the 
face and forearms after exposure, but no objective evidence of skin 
irritation was found. The most severely affected men lost 4.5-11 workdays; 
those least affected lost no work time.
Pulmonary function tests, including forced vital capacity (FVC), 
forced expiratory volume, maximal expiratory flow rate, 200-1,200 cc flow
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rate, maximal midexpiratory time, and forced inspiratory vital capacity, 
were conducted 2 and 4 weeks after exposure [19]. All the test findings 
were normal, except for one man who had a decreased FVC that was attributed 
to an unnamed preexisting pleural disease. Routine urinalysis findings 
were normal, while spectrographic analysis showed vanadium in the urine of 
12 men. The actual vanadium content was not reported. The workers who 
were the most severely ill excreted vanadium for up to 2 weeks, after which 
no vanadium was detected in the urine in any of the men. A throat culture 
from one man and chest roentgenogram findings in all of the men were 
normal. Leukocyte counts were elevated above the normal range in nine men 
during exposure (range 10,000-16,000 cells/cu mm, the highest counts being 
found in the most severely affected workers). Five men had normal counts 
3-5 days after removal from vanadium exposure, and one had elevated 
leukocyte counts with an elevated number (unspecified) of lymphocytes 
during the entire 2-week period of observation. One worker with a viral 
infection had a lowered leukocyte count. All others were normal by the end 
of the 2-week observation period. The authors suggested that the prompt 
return to normal leukocyte counts tended to substantiate the similarity of 
the vanadium intoxication aftereffects to those of zinc oxide type "metal 
fume fever."
After recovery, several workmen, especially those with multiple 
exposures, found it impossible to participate in cleanup activities because 
of recurrent coughing and wheezing [19]. Respirators were inadequate to 
prevent signs or symptoms from occurring. Although these recurrent signs 
or symptoms appeared to be more severe than those of the original illness, 
indicating possible sensitivity effects, there was no clinical evidence
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that they were of longer duration. Four men, reexamined while experiencing 
recurring signs or symptoms during the cleanup operation, had normal 
ventilatory function. No other test results were reported. The authors 
believed that the vanadium intoxication was caused by the high purity of 
vanadium pentoxide, the small particle size, and the possible presence of 
vanadium pentoxide fume in the pelletizing process.
An interesting aspect of the report was the increased severity and 
rapid onset of the symptoms in the workers after multiple exposures, even 
though subsequent exposure concentrations were said to be less severe than 
those responsible for the initial illness. The authors [19] suggested that 
this sequence of events could represent a sensitivity reaction rather than 
an effect of accumulated vanadium. They recommended diligent engineering 
controls and individual protective equipment, such as air-line respirators, 
when handling vanadium. They also recommended a réévaluation of the 
acceptable TLV's for vanadium and its compounds.
In the only report of human exposure to ferrovanadium, Roberts [20], 
in 1965, presented a review of 15 years' experience as medical director of 
a ferroalloy plant. The average plant population was 2,000 people who were 
moved from department to department and from process to process. The 
employees were examined routinely every 3-5 years, and the examinations 
included: chest and lumbar spine roentgenograms, electrocardiograms, vital
capacity studies, urine analyses, and audiograms. Concentrations of the 
compounds discussed were not given.
According to the author [20], ferrovanadium produced only slight 
irritation to the respiratory tract and eyes. Vanadium-aluminum alloy at 
particle sizes less than 100 mesh (about 150 /Ltm [21]) produced irritation
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of the nose and throat with coughing. The posterior of the tongue became 
greenish-gray after 4 hours exposure to the finer sizes. Vanadium carbide 
was reported to be essentially inert physiologically. No serious health 
hazard was noted and sizes down to 100 mesh caused little irritation of the 
eyes and respiratory tract.
In 1953, Tara et al [22] observed vanadium intoxication in four male 
dock workers, 30-40 years old, who unloaded bags of calcium vanadate from a 
ship for about 1.5 days. Concentrations of the calcium vanadate at which 
these workers were exposed were not reported. Fifty-kilogram paper bags of 
calcium vanadate were normally lifted out of a ship's hold by rollers and 
then carried to port warehouses; however, 30% of these bags had broken, so 
the dockers had to climb into the hold and shovel the spilled calcium 
vanadate, 10-15 cm thick, into other bags, thereby creating a dusty work 
environment. The dockers became ill after an unspecified time in the hold 
and had to interrupt their unloading task. The unloading was finished 
several days later by workers wearing filter masks.
The four dockers showed respiratory symptoms of varied intensity that 
forced them to leave work for periods from 0.5 day to 3 weeks [22]. 
Coughing occurred in three workers and wheezing, expectoration of mucus, 
and signs of bronchitis were noted in two workers. Also reported were 
"febrile movement" in one docker, expectoration of bloody mucus and a 
feeling of depression in another, and headache, stiffness, and vomiting in 
a third docker. The latter two were hospitalized for 7 and 9 days, 
respectively. Tara et al also reported that, prior to employment, one of 
the four dockers had pleurisy, another had heart disease, and a third had 
bronchitis.
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Sjoberg [23], in 1955, examined 21 men who cleaned oil burners. 
Seven men cleaned very large oil burners (20-30 tons of heavy oil 
burned/hour), 1 man cleaned a small oil burner (1/25-1/50 the size of the 
ones previously mentioned), and 13 men cleaned a medium-sized oil burner 
(45 tons of oil burned/24 hours) . Air sampling methods were not described 
for any of these processes. Chest radiography in one man and tests for 
vanadium content in the blood and urine of another man were the only 
examinations specified in the study.
The first seven men were exposed to vanadium pentoxide dust at 
concentrations of 85, 57, 10, and 2 mg/cu m with most particle sizes being 
between 10 and 20 trn. in diameter [23]. Face masks were worn but did not 
appear to be effective. Of the seven men, all had irritation of the nose, 
six had coughing with irritation of the throat and bronchi, five had 
wheezing in the chest, three had irritation of the eyes, three were 
fatigued, two had palpitations of the heart, and one had difficulty in 
breathing. All of the men had one or more signs or symptoms and these were
considered typical of vanadium bronchitis. On radiography, one man showed
bilateral bronchopneumonia. In one man, chemical analysis of the blood 
failed to detect vanadium, but 5 mg/100 ml was found in his urine 16 hours 
after his exposure; thus, distinct excretion of vanadium was demonstrated.
The signs and symptoms usually appeared 1-2 days after working in the
boilers and usually disappeared a few days after removal from the cleaning 
area. Sjoberg noted that sulfur dioxide and sulfur trioxide were present 
in the boilers before they were purged with fresh air. These sulfurous 
gases occurred after burning the high-sulfur content oil. However, he 
stated that the gases could not play an important part in the causation of
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the respiratory effects because of their volatility and the small amounts 
present when the boilers had been cooled prior to cleaning. Corrosion of 
the clothes was noted by six of the workers, but this was from the 
formation of sulfuric acid in the boiler after wetting the fly-ash 
(containing sulfur compounds).
The man who cleaned the small boiler had coughing, wheezing in the 
chest, and irritation of the throat and bronchi [23] . He recovered about a 
week after removal from the work area. No exposure concentration for 
vanadium pentoxide dust was given.
Of the 13 men who cleaned the medium-sized boilers, all had coughing, 
12 had irritation of the eyes, nose, and throat, 10 had rashes, 9 had
irritation of the bronchi, 7 had difficulty in breathing and fatigue, 3 had 
wheezing in the chest, and 1 had palpitations of the heart [23]. All the 
men had one or more of the signs or symptoms and these usually appeared on 
the day after cleaning; however, some signs or symptoms appeared
immediately after exposure, but this was considered to be from the high 
concentration of sulfur dioxide and trioxide gases in the boilers. 
Sjoberg's explanation was that, in the 13 men, the complaints usually 
appeared after a few days work and, thus, were typical of vanadium exposure 
and not characteristic of sulfur dioxide or trioxide exposure. The
corrosive effect on the clothes from the sulfuric acid-containing soot was
again evident. The men were instructed to wear face masks but apparently 
did not always do so as indicated by the reported signs and symptoms.
Sjoberg [23] noted that exposure to vanadium pentoxide dust was 
mainly an acute irritation of the upper respiratory tract and conjunctiva 
with associated respiratory problems, including bronchitis. No greenish-
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black discoloration of the tongue (an indicator of vanadium exposure [24- 
26]) was reported in any of the 21 men examined. Recommended control 
measures included the use of respirators and protective clothing, purging 
the boiler with air before entering, and burning a combination of oil and 
pulverized coal to decrease vanadium pentoxide deposits.
Fallentine and Frost [27], in 1954, analyzed soot from oil-fired 
boilers and found that it contained both vanadium and sulfuric acid.
In 1952, Williams [28] examined eight men who were exposed to 
vanadium pentoxide dust at concentrations ranging from 17.2 to 58.6 mg/cu m 
for periods of 2-5 days while cleaning the combustion chambers, fire 
bricks, and heating tubes of oil-fired burners. The protective equipment 
worn by the cleaners was not described, but photographs in the article 
depicted the men wearing some type of filter mask, cap, and coveralls. The 
primary symptoms appeared 0.5-12 hours after the workers started cleaning 
and consisted of sneezing in five, rhinorrhea in seven, sore throats in 
two, tightness of the chest in three, and chest pains in one. After 6-24 
hours, secondary symptoms and signs appeared consisting of coughing in all 
eight, breathing difficulties in seven, depression in four, rales in three, 
fatigue in three, rhonchi in two, hand tremors in two, and wheezing in one. 
A yellow to greenish-black coating of the tongue was observed in all of the 
men, but the color faded within 2-3 days after removal from the work area. 
The coughing sometimes became spasmodic and productive and induced vomiting 
in one man. All of the workers had more than one sign or symptom and these 
continued while the men were working but became less severe 3 days after 
ceasing work. In one man the wheezing and breathing difficulties persisted 
for over a week, but no permanent effects were noted. Postexposure blood
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pressures were lower than preexposure measurements in seven of the eight 
men, and in one man, there was no change. Williams suggested that the 
workers' familiarity with medical examination procedures when the 
postexposure readings were taken might have explained the measured blood
pressure differences. The results of cardiac examinations, including 
electrocardiograms and roentgenograms of the chest, showed no 
abnormalities. The author entered an oil-fired burner for 1 hour during 
its cleaning and experienced most of the symptoms previously mentioned, as 
well as coughing which persisted for 2 weeks.
Urine samples from the men were analyzed for vanadium content using 
the phosphotungstate colorimetric method of Sandell [29]. Specimens for 
each man were collected over a 24-hour period on the last day of boiler 
cleaning, precautions being taken to prevent contamination. In the most 
severely affected worker (5 days of exposure), concentrations of 0.07 mg 
(early morning specimen) and 0.4 mg (daytime specimen) of vanadium/liter of 
urine were found, while no vanadium or only traces of vanadium were found 
in the urine of five and two men, respectively. Urine specimens from all 
of the men showed no albumin, sugar, or blood. Electrocardiograms in all
the men were normal.
Sampling was carried out during the cleaning operation by drawing
dust-laden air through distilled water contained in an aspirator packed 
with Lessing rings [28]. Three separate samples of 3.7, 4.5, and 6.8 cu m 
of air were collected at a flowrate of about 7.1 cu m/hour. Vanadium was 
estimated both in the resultant solution and in the suspended solids. 
Thermal precipitator samples were used to estimate particle size and 
concentration. Results of the dust sampling indicated that there were
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3,500 particles/ml (about 84 million particles/cu ft) of air. About 94% of 
the particles were 1 jum or less in size; particle sizes ranged up to 11 ¡ x m  
in diameter. Vanadium was present in the atmosphere at concentrations of 
17.2 and 40.2 mg/cu m in the two superheater chambers and 58.6 mg/cu m  in 
the combustion chambers.
Williams [28] recommended improved measures for cleaning the burners, 
such as cleaning them from the outside, wearing proper respirators, 
spraying water to reduce dust, and using a tarpaulin to protect workers 
from falling dust. These methods were subsequently tried and no further 
adverse effects were reported. Williams also suggested improvements of 
boiler cleaning techniques, which included reduction of exposure to 
petroleum soot and medical supervision of the workers throughout the 
cleaning process. According to the findings of Sjoberg [23], sulfates 
could have been present and may have caused some of the irritant effects.
Browne [30], in 1955, described vanadium poisoning in 12 men who used 
pneumatic chisels to cut away combustion residues from heat exchanger tubes 
of a gas turbine engine. Exhaust air from the chisels caused the dust 
(mainly vanadium pentoxide and probably vanadium silicates and vanadates), 
which contained about 11-20% vanadium, to become airborne. The time of 
onset of signs and symptoms ranged from 1 to 14 days. The average time 
before these signs and symptoms appeared was 4.2 days. Nosebleed was the 
first sign noticed in five men, followed by other respiratory signs and 
symptoms, such as coughing in six, tightness and pain in the chests of 
five, nasal congestion and wheezing in four, and difficulty in breathing in 
two. Alimentary signs and symptoms were reported in seven men and included 
black tongue in six, four with an odd taste in the mouth, two with black
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teeth, and one with nausea and diarrhea. Skin problems, caused by damp 
conditions that yielded an irritating acid solution, were also reported by 
seven men and consisted of sore skin in three, one with rash, and one 
unspecified condition. "Smarting eyes" were reported by two workers. 
Analytical and sampling methods for the dust and exhaust gases were not 
described.
McTurk et al [31], in 1956, reported no evidence of effects on boiler 
cleaners working in an atmosphere containing vanadium pentoxide at an 
average concentration of 99.6 mg/cu m. They noted that the lack of effects 
was probably because of the gauze filter masks worn over the nose and mouth 
and because of the intermittent cleaning operation that occurred only one 
or two times each month. No sampling or analytical methods were presented.
In 1967, Zenz and Berg [32] placed nine healthy volunteers, 27-44 
years old, in an environmental chamber and exposed them to pure vanadium 
pentoxide dust for periods of up to 8 hours. The environmental chamber was 
an enclosed room, 660 cu ft in volume, air conditioned to maintain constant 
temperature and humidity, and was equipped with a dust-feed mechanism to 
deliver the vanadium pentoxide. Air samples were drawn directly from the 
chamber using glass-fiber filters with a flow-calibrated vacuum pump, and 
they were analyzed by the spectrophotometric method of Hulcher using 
benzohydroxamic acid [33]. Particle size analysis showed that 98% of the 
collected dust was less than 5 ¿urn in diameter. Before exposure, pulmonary 
function tests were conducted on the subjects on three separate occasions 
to obtain baseline measurements. Complete physical examinations were 
conducted prior to exposure and included chest roentgenograms, complete 
blood counts, and hematocrit measurements. Urine and feces were tested for
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vanadium content by the spectrophotometric method of Hulcher [33] . Blood 
samples were drawn 3 weeks before and 3 weeks after exposure for 
determinations of serum cholesterol, total lipids, and triglycerides, but 
the results obtained were too varied to be used. Cystine analysis of the 
hair and nail clippings was performed by the Public Health Service before 
and after exposure, but no differences were found.
Two volunteers were exposed to vanadium pentoxide dust at a 
concentration of 1 mg/cu m  (0.6 mg V/cu m) rather than the planned 0.5 
mg/cu m  (0.3 mg V/cu m) during the first 8-hour test [32]. They developed 
some sporadic coughing after the 5th hour, and more frequent coughing at 
about the 7th hour of the test. No other signs of irritation were noted. 
Results of postexposure chest roentgenograms, urinalyses, leukocyte and 
differential counts, nasal smears, and pulmonary function tests were the 
same as those obtained before exposure.
The same two volunteers were accidently reexposed for 5 minutes to a 
heavy cloud of vanadium pentoxide dust of unknown concentration 3 weeks 
after the original exposure [32]. Sixteen hours later, marked, productive 
coughing developed. The next day, rales and expiratory wheezes were
present, but pulmonary function was normal. Treatment with 1:2,000
isoproterenol for 5 minutes by positive pressure inhalation relieved the
coughing and wheezing; however, coughing resumed in an hour and continued
for 1 week. No other signs or symptoms were reported by the authors.
Zenz and Berg [32] then exposed five volunteers for 8 hours to 
vanadium pentoxide dust at a concentration of 0.25 mg/cu m (0.1 mg V/cu m ) . 
Air sample findings showed an average concentration of 0.2 mg/cu m with a 
standard deviation of 0.06 mg/cu m, and the microscopic analysis showed
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that 98% of the collected dust was again less than 5 jum in diameter. All 
of the volunteers developed a cough the next morning, but differential 
leukocyte counts were normal. Daily observations of the volunteers found 
no abnormalities. Coughing ceased after 1 week in several of the 
volunteers and after 10 days in the remainder. No pulmonary function
changes from preexposure values were noted immediately after exposure or 2 
weeks later. For vanadium analyses, postexposure blood samples were drawn 
every other day for 8 days and daily urine samples were collected for the 
same period; after 1 week, these samples were taken every other day for 14 
days. Feces were collected and analyzed for vanadium content. No vanadium 
was found in blood samples, while the vanadium content of the urine was 
greatest, 0.013 mg/100 ml, at 3 days after exposure, and none was found
after 1 week. Maximum fecal vanadium content was 0.3 mg/100 g; none was
detected after 2 weeks.
Because of the responses at 0.2 mg/cu m, two volunteers, not 
previously exposed to vanadium pentoxide dust, were exposed at 0.1 mg/cu m 
for 8 hours [32] . No symptoms occurred until about 24 hours after exposure 
when considerable mucus formed that was easily cleared by slight coughing. 
The coughing increased after 2 days, subsided within 3 days, and
disappeared completely after 4 days. There were no deviations from normal 
in undefined laboratory studies. The acute manifestations of pulmonary
irritation observed in all volunteers demonstrated the reaction of humans 
to fine vanadium dust of less than 5 jum. Despite the distinct clinical 
picture of pulmonary irritation in all the subjects, pulmonary function 
tests remained unaltered [32]. No systemic complications were found.
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Zenz and Berg [32] pointed out that their experiments were conducted 
under resting conditions, and, thus, under actual working conditions, there 
would be an even greater inhalation and absorption at the same 
concentrations of vanadium pentoxide dust. However, an experiment with 
volunteers engaged in physical activity was not conducted. Because of the 
responses at 0.1 mg/cu m, the authors recommended that the TLV of 0.5 
mg/cu m  for vanadium pentoxide dust be lowered. Control groups were not 
used and exposure experiments at lower concentrations of vanadium pentoxide 
dust were not performed.
In his review of vanadium toxicology in 1964, Hudson [34] reported 
his personal experience supervising 18 workers who were exposed 
intermittently to vanadium pentoxide and ammonium metavanadate in fine 
particles, mostly less than 1 (im  in size and at an average air
concentration of 0.25 mg/cu m  (range 0.08-0.76 mg/cu m) as vanadium
pentoxide. He observed that if the workers did not wear respirators, a 
discolored tongue, metallic taste in the mouth, throat irritation, and 
slight coughing often developed. Thus, the author concluded that the 
maximum permissible concentration of vanadium pentoxide dust should be 
lowered to 0.1 mg/cu m.
Roshchin et al [35] examined 120 workers exposed to dust containing 
up to 10% vanadium trioxide and up to 9% vanadium pentoxide. Three cases
(two women and one man, between 33 and 40 years old) of bronchial asthma in
120 subjects had developed after contact with vanadium for 1-5 years. 
Removal from contact with vanadium relieved the condition somewhat, but it 
was not completely eliminated; if contact with the dust was renewed, the 
condition of the workers deteriorated. This was said to confirm that
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vanadium could cause bronchial asthma. Similar findings, suggestive of an 
allergic effect, have developed in other human studies [19,26,36]; such an 
effect has also been demonstrated in animal studies [35] .
Similar effects (respiratory tract, eye, and possible skin 
irritation) have been found in other studies [37-52] of industrial vanadium 
exposure.
Kent and McCance [53] examined the routes of excretion of sodium 
tetravanadate in humans. The authors did not define sodium tetravanadate 
but a previous study [12] described it as Na2V4011. They injected sodium 
tetravanadate iv at an unspecified dose into two men daily for 6 days. The 
men were fed a vanadium-free diet. Analyses for vanadium content in the 
food, urine, and feces were performed spectrochemically. After the last 
injection, the total vanadium excretion by each of the two subjects by the 
7th day was 93% and 89%, respectively. The authors concluded that 
vanadium, when present in the bloodstream, was mainly eliminated by the 
kidneys, since 81% of the total vanadium injected into the two subjects was 
excreted in the urine, and there was only 9% in the feces by the 7th day 
after the last injection. The authors presumed that unrecovered vanadium, 
about 10% of the administered dose, remained in the body.
In 1963, Dimond et al [54] administered ammonium vanadyl tartrate 
orally to five women and one man, 30-55 years old, to establish levels of 
tolerance, relationship between oral dose and urinary excretion, evidence 
of toxicity, and the effect on circulatory lipids. The tartrate was 
administered orally in 25-mg tablets, up to four times/day with meals, for 
45-68 days. The amount of vanadium excreted in the urine was determined by 
the colorimetric method of Talvitie [55] using 8-quinolinol; urine
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specimens were also examined microscopically. Total lipids, phospholipids, 
triglycerides, and total and free cholesterol were measured in the venous 
blood of all subjects; in three subjects, 17-ketosteroids and 17- 
hydroxycorticosterolds were also measured. Other analyses conducted were 
blood urea nitrogen (BUN) concentration, serum glutamic-oxaloacetic 
transaminase (SGOT) activity, and reticulocyte, platelet, and total and 
differential leukocyte counts.
The vanadium content of urine was determined in four subjects during 
the 24-hour period after administration of the tartrate at varying doses of 
25-125 mg [54]. In all cases, wide fluctuations in urinary excretion 
suggested unpredictable absorption of the tartrate. No laboratory findings 
indicative of toxicity occurred. Reticulocytes, platelets, and total and 
differential leukocyte counts were within normal limits. BUN and SGOT 
values were unchanged. Three of the women excreted 11.8-18.2 mg of 17- 
ketosteroids/24 hours (normal, 5-15 mg/24 hours' volume, excreted as
dehydroisoandrosterone) and 6.1-9.5 mg of 17-hydroxcorticosteroids/24 hours 
(normal, 5-10 mg/14 hours' volume). All subjects reported gastrointestinal 
difficulties manifested by black, loose stools and increased intestinal 
activity accompanied by cramps. On a daily dose of 50 mg or more, a 
purple-green tint developed on the tongue but disappeared promptly. Two 
subjects said they experienced greater fatigue and lethargy than usual 
while taking vanadium. A cholinergic-blocking drug (triglyclamol chloride) 
given with each dose of ammonium vanadyl tartrate seemed to lessen the 
intestinal symptoms and to permit administration of a larger dose of the 
tartrate. The total daily dose tolerated varied from 50 to 125 mg. No 
statistically significant changes occurred in blood lipids, phospholipids,
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triglycerides, or cholesterol. There were no measurable toxic effects of 
ammonium vanadyl tartrate on the bone marrow, liver, kidneys, or adrenal 
glands.
In 1962, Somerville and Davies [56] treated 12 patients, 23-64 years
old, with oral doses of diammonium vanado-tartrate for 6 months to test its
effect on serum cholesterol concentrations. All of the patients were on a 
diet restricted in fat. Nine of these had hypercholesterolemia (seven also 
had ischemic heart disease) and three had ischemic heart disease with 
normal serum cholesterol concentrations. The tartrate was given in doses 
of 25 mg three times daily for 2 weeks, 125 mg for the next 2 weeks, and 
this dosage was maintained further for 5 months in 10 patients; during the 
5th month, administration of the drug was stopped in 2 patients because of 
toxic gastrointestinal effects. Blood samples were drawn and analyzed for 
serum cholesterol by paper electrophoresis [57] three times before 
diammonium vanado-tartrate administration, monthly during administration,
and for 2 months after administration stopped. Vanadium content in the
urine was detected by the colorimetric method of Rockhold and Talvitie in 
which vanadium forms a magenta color with p-aminodiethylaniline [58]. 
Blood urea, hemoglobin, lipoprotein, and urine albumin were determined 
before and during administration of the tartrate.
Statistical analysis indicated that there was no significant effect 
on serum cholesterol values [56] . Lipoprotein, blood urea, hemoglobin, and 
urine albumin were unchanged. Five patients had upper abdominal pain, 
nausea, and losses in appetite and weight. Symptoms in three of these 
patients improved after the doses were reduced, and, in the other two 
patients, the drug was stopped after 4 months. Green tongue appeared in
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five patients and a sixth developed pharyngitis with marginal ulceration of 
the tongue. Vanadium was found in the urine of nine patients; however, no 
quantitative measurements were made.
Effects on serum cholesterol levels have been investigated and can be 
found in reviews elsewhere [59-61].
The most common route of entry for vanadium in industrial situations 
reported above was via the respiratory tract, although entry by the oral 
route could occur and lead to greenish-black discoloration of the tongue. 
Stokinger [62], however, noted that sodium metavanadate was absorbed 
through the skin of animals (unspecified) when applied as a 20% solution 
and acted as a primary irritant to human skin at a concentration of 10%. 
Ammonium metavanadate and vanadium pentoxide in 0.5 and 0.8% solutions, 
respectively, did not irritate the skin. His conclusions, however, were 
not supported by any data. No other reports of skin absorption have been 
found in the available literature.
Thus, in summary, the most commonly described and best documented 
effects of short-term exposure to vanadium, primarily to vanadium pentoxide 
dust, in the previous studies were respiratory tract, eye, and possible 
skin irritation. Major signs and symptoms demonstrated were coughing, 
wheezing, difficulty in breathing, bronchitis, and chest pains. A 
greenish-black discoloration of the tongue was reported in some of the 
studies, but was considered an indicator of exposure rather than a sign of 
intoxication. Symptoms usually ceased shortly after removal from the 
exposure area. No systemic, carcinogenic, mutagenic, teratogenic, or 
reproductive effects from vanadium exposure were indicated by the limited, 
often short-term, studies. Some of these studies suffered from a lack of
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pertinent data, ie, on duration of exposure, on concentration of airborne 
vanadium, on sampling and analytical methods, and on specific forms of 
airborne vanadium found. Interestingly, in the boiler-cleaner studies, 
sulfur trioxide and dioxide were implicated as a possible cause of some of 
the signs or symptoms attributed to vanadium. However, since these effects 
have been seen in the absence of exposure to sulfur oxides, eg, in bagging 
operations, in crushing operations, and in experimental exposures, it seems 
correct to attribute the effects in the boiler studies to exposure to 
vanadium compounds. Possibly sulfur oxides enhanced the effects of 
vanadium in the boiler studies.
Epidemiologic Studies
The following studies of workers exposed for a long time indicated 
that exposures to vanadium caused signs and symptoms similar to those of 
the short-term studies described above. Again, the irritant effects were 
reversible on cessation of exposure. There were, however, more severe 
conditions reported, ie, emphysema and pneumonia, but the available data 
make these reports less than certain.
In 1939, Symanski [63] described vanadium poisoning in 19 vanadium 
plant workers exposed to vanadium pentoxide dust at unknown concentrations 
over a period of a few months to several years. The technical processes of 
producing vanadium pentoxide, pure vanadium, and ferrovanadium were 
described. Those parts of the production processes involving mixing, 
scraping, leaching, and shoveling of material produced clouds of dust. 
Medical procedures used by the author included medical and work histories 
and subjective complaints, examination of the chest, heart, and abdominal
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organs, neurologic and radiologic examinations, routine blood and urine 
analyses, and sputum tests.
The medical examination showed no evidence of gastrointestinal 
disturbances or evidence of disease in the blood, kidneys, or nervous 
system, and sputum test results were negative for evidence of tuberculosis. 
Of the 19 workers, 18 had coughs, 13 showed reddening of the nasal mucosa 
(rhinitis) and surrounding tissue, 12 had wheezing, humming, or whistling 
sounds in the lungs, 10 had burning eyes, 9 expectorated mucus or had
rhinorrhea, 7 had tightness or pain in the chest, 5 had excessive eye 
secretions, 4 sore throats were evident, 3 demonstrated sneezing and had 
radiologic expression of chronic bronchitis (only 1 worker had both 
simultaneously), and 2 had rhonchi, bronchitic cough, or colds. All of the 
workers had more than one sign or symptom. Symanski pointed out that 
severe chronic bronchitis might occur, perhaps progressing to 
bronchiectasis, with continued exposure.
Symanski [63] recommended the mechanization and enclosure of all work 
processes that were dusty in nature, use of dust masks, and proper training 
of a large number of workers so that work with vanadium would be 
intermittent rather than continuous. The author concluded that vanadium 
pentoxide dust had primarily an irritant effect on the respiratory system 
and conjunctiva and that there was no reason to suspect that vanadium had 
any adverse systemic effects on the body. There were no data presented on 
the concentrations of vanadium pentoxide dust produced throughout the 
plant.
In a later (1954) report, Symanski [64] described 17 occurrences of 
vanadium intoxication at the same vanadium plant, 10 of which he observed
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in 1952 and 7 followups from his 1939 study [63], described above.
Technical changes had been made at the vanadium plant since 1939, 
including a wetting process to reduce airborne dust, which reduced the 
number and severity of disorders caused by vanadium pentoxide [64] . A 
majority (number not given) of the 10 vanadium plant workers observed in 
1952 and employed for 2-3 years complained of rhinorrhea, coughing, and 
occasional lacrimation. Although bronchitis was diagnosed in several of 
the workers, all examinations, including roentgenograms, showed no 
irregularities and the general health of the subjects was not impaired. 
The seven followup workers, men 38-60 years old employed for 2-13 years at 
the plant, were examined for residual signs and symptoms and chronic 
disorders caused by vanadium pentoxide dust exposure. All seven workers 
had the characteristic disorders of vanadium intoxication while working in 
the vanadium plant, ie, irritated mucous membranes of the eyes and upper 
respiratory tract, discharge from the mucous membranes, head colds, 
sneezing and nosebleeds, sensation of pain in the pharynx, coughing with 
some expectoration, chest pains, and difficulty in breathing. Two workmen 
who had been employed for the longest periods, 9 and 13 years, were 
diagnosed as having emphysema, but Symanski stated that it was impossible 
to definitely implicate vanadic acid (vanadium pentoxide) because of the 
age of the men involved and "other factors" that could have contributed to 
this disease. However, because chronic bronchitis can lead to emphysema, 
the author was inclined to attribute a substantial amount of the damage to 
repeated inhalation of vanadium dust.
The author [64] concluded that the reduction of adverse effects on 
the 10 workers was because of the modification of technical procedures used
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in the vanadium plant, and that the effects of long-term exposure in the 
form of emphysema on 2 of the 7 followup workers were partially from the 
greater amount of vanadium exposure in the early years of the plant
operation. The concentrations of vanadic acid (vanadium pentoxide) to
which the 17 workers were exposed were not given.
Wyers [24], in 1946, described 10 occurrences of vanadium pentoxide 
dust exposure observed over a 9-year period in 50-90 vanadium plant 
workers. Length of exposure to the vanadium pentoxide dust (10-15% 
vanadium pentoxide; other components unspecified) for the 10 men, 30-63 
years old, ranged from 5 months to 16 years (mean of 6 years) The dusty 
conditions were caused by the crushing and grinding of the raw materials 
(all containing vanadium pentoxide) used in the plant, that is, soot from 
oil-burning ships, furnace residues from oil refineries, and slags from the 
production of ferrovanadium.
The workers' complaints included coughing in eight, difficulty in 
breathing in six, pain and tightness in the chests of four, sputum in three 
(one bloodstained), salty taste in the mouths of two, heart palpitations on 
exertion in one, exhaustion in one, and attacks of pleurisy in two [24].
Medical examination of the workers showed four with rales and four with
rhonchi, four with lung reticulations in roentgenograms, three with 
accentuated pulmonary second sound, two with linear striations in lung
roentgenograms, tremors in the hands of two men, emphysematous-type chest
in two (one had emphysema), and two with greenish-black tongues (an 
indicator of exposure rather than intoxication, according to Wyers). 
Medical examination also showed one instance each of left ventricle
enlargement, pale skin, bronchitis in a worker who had had the condition
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prior to working in the vanadium plant, and prolonged expiratory sounds. 
Three workers developed pneumonia and one died. All the workers had more 
than one sign or symptom. While the author believed that increased blood 
pressure was an effect of vanadium intoxication, it could not be 
ascertained that blood pressure was truly elevated in the 10 workers 
because of the lack of preexposure blood pressure data.
Wyers [24] suggested that colds and pneumonia were more frequent in 
vanadium workers than in the general public; however, no data were provided 
to substantiate this. He also did not report concentrations of vanadium 
pentoxide dust at which the 10 workers were exposed or provide any 
quantitative data correlating exposure and effect.
In 1950, Sjoberg [26] published the findings of his 2-year 
observations of 36 vanadium production workers, ages 20-59 years, who had 
inhaled 0.03-5.58 mg/cu m  of vanadium pentoxide dust. Only 9 of the 36 men 
had any previous exposure to vanadium. The plant received slag containing 
what was stated to be FeV204 and vanadium trioxide, which was then 
crushed, pulverized, and mixed with soda, probably soda ash. 
These steps were followed by warm water extraction, precipitation, and 
drying of the vanadium pentoxide to yield a brownish-red powder containing 
85-90% vanadium pentoxide. The bulk of vanadium pentoxide was packaged in 
paper bags and delivered to manufacturers of ferrovanadium. Some of the 
vanadium pentoxide was used as a catalyst in a sulfuric acid production 
plant. When the vanadium production plant was first opened, all workers 
were constantly exposed to the dusts at high concentrations; however, 
better engineering controls were installed during the following years, and, 
consequently, dust concentrations were greatly reduced. The exception to
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this was at the catalyst plant where there still were dust problems. Dust 
masks and pressure-air masks were distributed to all employees handling 
vanadium-containing material at about the same time engineering controls 
were installed in the plant.
Dust was measured with a konimeter, and particles were counted using 
a microscope [26]. Detailed medical examinations were conducted at the 
beginning and at the end of the observation period (most of the clinical 
reports covered a 1-year period). The tests included chest roentgenograms; 
spirometric, laryngoscopic, and bronchoscopic examinations of the 
respiratory tract (the same otolaryngologist examined the men throughout 
the observation period); hemoglobin measurements, erythrocyte, leukocyte, 
and eosinophil counts; erythrocyte sedimentation rate; serum bilirubin 
content; serum alkaline phosphatase value; thymol turbidity values; formol- 
gel test; Takata's serum test (for liver function); vanadium content of the 
blood and urine (by optical spectral analysis); and urine analyses for 
albumin, specific gravity, urobilin, and sediment. Electrocardiographic 
examinations were conducted at the beginning of the observation period, 
once after that, and after exertion (running up four flights of stairs) in 
31 of the men. Patch tests using a 2% sodium metavanadate solution and a 
skin biopsy from the test site were performed. A group of 703 workers from 
mines and sawmills, who had presumably only been exposed to inert dust, 
were used as controls. Statistical analyses were performed with the use of 
the Student's t-test.
Dust concentrations in the air of the plant ranged from 0.6 to 87 
mg/cu m, with the vanadium pentoxide concentrations in three areas of the 
plant calculated at 0.03-5.58 mg/cu m [26]. The particle count varied from
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6 to 140/ml, of which 22% were less than 8 /im and 39% less than 12 ¿rai. Six 
men had slight conjunctivitis. Nasal mucous membrane inflammation 
incidence was high at the first examination. Dryness or smarting of the 
nose, blocking of nasal passages, or sores in the nostrils were observed. 
All of the incidences were generally moderate, and no perforations of the 
nose were noted. The proportion of vanadium workers with normal nasal 
conditions was less than that in the controls (61% versus 80%) . Complaints 
of dry, irritated, or painful throat were reported by the vanadium workers. 
Normal conditions of the throat were observed in 42% of the vanadium 
workers versus 64% of the controls. The larynx was normal in 42% of the 
vanadium workers versus 88% of the controls. Hoarseness was an occasional 
complaint, but no severe changes of the throat were observed. 
Laryngoscopic examinations of the trachea showed that both controls and 
vanadium workers had about the same percent of normal conditions.
At the last examination of the upper respiratory tract, the incidence 
of normal conditions was less than at the first examination for the nose 
(50% versus 61%), throat (10% versus 42%), and larynx (27% versus 42%). Of 
the noses examined, a majority showed chronic increased thickness and edema 
of the nasal mucosa, several of which were described as allergic in type. 
There was only slight irritation to the larynx and throat with some 
atrophic changes.
Bronchitis was common during the period of exposure and was far more 
common in the exposed men than in the control group; the average length of 
incapacity from bronchitis was 13 days [26]. Of the 36 men examined, 31 
had wheezing in the chest, 27 had shortness of breath, 22 had dry coughing, 
and 14 had productive coughing. Some complained of a violent choking
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cough, especially at night. There was no blood-stained sputum. Rales were 
frequently heard on auscultation, but bronchoscopy performed on four 
workers showed three with no more than slight inflammatory changes and one 
with intensely reddened tracheal mucosa.
Acute changes occurred in the lungs of five men, pneumonia in one and 
bronchopneumonia in four; three of these men had been heavily exposed to 
dust at work [26] . Two other men who had left the plant also had 
bronchopneumonia. These were considered as probable incidences of 
pneumonitis caused by vanadium pentoxide dust and bacteria. An allergic 
factor also may have been involved, as one of the five workers had 
eczematous lesions and reacted positively to a vanadium patch test. No 
signs of emphysema or fibrosis of the lungs were demonstrated either on 
radiographic or spirometric examination. Because of the short observation 
period, Sjoberg didn't rule out possible lung changes, and he recommended 
followup examinations to answer that question.
Skin lesions were found on several workers during the observation 
period, particularly during the 1st year of plant operation; these included 
eruptions primarily on the face and hands [26]. Only one man demonstrated 
allergy by reacting positively to patch tests given at the beginning and 
end of the observation period. Microscopic examination of a biopsy
specimen from the site of this worker's allergic lesions verified an
eczematous reaction. The alkaline soda used in the factory may have been 
responsible for some of the skin lesions.
The number of positive urobilin reactions in the vanadium workers was 
no higher than in the controls [26]. Serum bilirubin and alkaline
phosphatase values were normal. Takata's serum test and the formol-gel
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test were negative. The thymol turbidity test mean values were slightly 
higher than normal both at the beginning and end of the observation period. 
In the absence of further evidence of liver lesions, a causal relationship 
with exposure to vanadium seems unlikely.
Greenish-black, discolored tongues were absent, as were intestinal 
symptoms [26], No severe weight loss was observed; on the contrary, most
workers gained weight. Fever was present only in the five men with
bronchopneumonia or pneumonia.
Electrocardiographic examinations showed extra systoles in three 
workers and transient coronary insufficiency in one man [26]. Palpitations 
of the heart on exertion and sometimes at rest were present in some cases. 
According to Sjoberg, it could neither be ruled out nor established that 
the observed abnormal changes in the heart might have been associated with 
exposure to vanadium. Accentuated pulmonary second sound and raised blood 
pressures were not found during the observation period. Hemoglobin values 
and erythrocyte counts decreased slightly, especially in "regular" 
employees of the plant, but these findings were considered to be within 
normal limits. No tendency toward decreased leukocyte counts was present, 
and increased eosinophil counts were observed only in one man who showed a
positive allergy to vanadium. No erythrocytes containing basophilic
granules (stippled cells) were observed. The erythrocyte sedimentation 
rate was slightly increased, probably caused by an increased tendency 
toward infection in the respiratory tract.
Weakness and fatigue were common symptoms after heavy exposure to 
dust [26]. Giddiness was observed in a few workers, but this was vague and 
unspecific and was not attributed to vanadium, since work histories and
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medical findings in these men indicated other functional causes. Tremors 
of the right hand and foot were found in one man, appearing 1 month after 
he had had pneumonia; the trembling disappeared in 2 weeks. Pupillary and 
patellar reflexes and smell and taste senses were normal. Symptoms of a 
neurasthenic character, such as tiredness, anxiety, and sleeplessness, were 
found but were attributed to aggravated respiratory symptoms or shift work.
The urine tests showed no signs of disease of the urinary tract that 
could have been caused by vanadium [26]. Vanadium content in the ash of 
the urine from workers ranged from less than 0.0003% to 0.002%. Controls 
had 0.0003% or less vanadium in the ash of the urine. Vanadium content in 
the ash of the blood ranged from less than 0.0003% to 0.001% in the 
workers. Controls had less than 0.0003% vanadium in the ash of the blood. 
The tests showed a greater amount of vanadium in the ash of the blood and 
urine of the exposed workers as compared with the controls and showed that 
vanadium was absorbed and then excreted. However, no relationship was 
found between the vanadium content of the urine or blood and occupational 
exposure to dust.
In 1956, Sjoberg [65] described a followup investigation from his 
1950 report [26] on 6 of the 36 workers with the most marked respiratory 
symptoms. All six of the men continued to work full time in the vanadium 
mills. The examination of the six men was conducted 8 years after the 
beginning of the initial observation period and 5 years after their last 
spirometric tests. Subjective complaints of bronchitis with rhonchi, 
resembling asthma, and bouts of labored breathing and fatigue were 
reported. Two men were found to have slight-to-moderate bronchitis, 
verified on bronchoscopy. No evidence of pneumoconiosis, emphysema, or
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other chronic disease related to employment was found. The mucous 
membranes of the respiratory tract showed no abnormalities; minor changes 
in electrocardiograms and poor performances on muscular tests were 
attributed to increasing age.
In 1968, Tebrock and Machle [36] described the exposure of plant 
workers during a 5-year period to europium-activated yttrium orthovanadate, 
a vanadium-bearing phosphor used in color television picture tubes. 
Exposures were studied in three factories, one engaged in the manufacture 
of the phosphor and its reclamation, and two involved with the finished dry 
phosphor and its application to the inside of the color television tubes, 
in addition to some reclamation processes. The population at risk averaged 
3,000 people with 18,000 man-years of exposure since operations began in 
1963. The most frequent exposure was to the finished product, with weekly 
brief exposures to the raw materials, the most important being vanadium 
pentoxide. No effects were observed that could be attributed to yttrium or 
europium, so all environmental data were based on vanadium (expressed as 
vanadium pentoxide) alone.
Seventy-five air samples, taken over 102 weeks in the worst exposure 
areas of the three factories, were collected on membrane filters and then 
analyzed for vanadium using an undescribed method. Analysis of the urine 
and blood for vanadium content, blood pressure measurements, pulmonary 
function tests, and 2,000 chest roentgenograms on 250 workers with the 
highest exposure possibilities, taken over an 8-year span from 1960 to 
1968, were completed. Concentrations of vanadium in the air ranged from 
0.02 to 3.2 mg V205/cu m  with a mean value of 0.844 mg/cu m; particle sizes 
ranged from less than 1 to 10 ptm with 90% being less than 1.5 jum in size.
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The vanadium content of the urine was never more than 0.05 mg/liter, and no 
blood abnormalities, elevated blood pressures, or changes in pulmonary 
function were noted. However, men working with vanadium pentoxide and not 
using proper respiratory protection occasionally had increased blood 
pressures that returned to normal quickly when exposure was reduced. The 
chest roentgenograms showed no changes that could be related to dust 
exposure, except for those in six men who had varying degrees of 
reticulation or increased bronchovascular markings at times. However, 
these varied from year to year, so no trend was discernible.
Clinical observations by Tebrock and Machle [36] showed that the most 
common effects in those exposed were conjunctivitis, tracheobronchitis, and 
contact dermatitis. Other signs and symptoms reported were greenish- 
colored tongue, irritated nasal passage with mucous discharge, irritated 
respiratory tract with bronchitis and bronchospasm (often enhanced on 
repeated exposure), chest pain, difficulty in breathing, coughing spasm, 
and occasional palpitations. Allergy was also a factor as some of the 
workers reacted positively to patch tests with a sodium metavanadate 
solution. No permanent damage or systemic effects were found. The authors 
concluded that the effects of exposure to the vanadium phosphor were mainly 
of an acute nature and reversible on cessation of exposure, but that some 
chronic changes in the mucous membranes were found, and that the 
incorporation of vanadium as the orthovanadate into the crystalline lattice 
of the phosphor apparently resulted in the formation of a compound of much 
lower toxicity than that of vanadium pentoxide alone. No data were 
presented to compare the toxicity of the phosphor to that of vanadium 
pentoxide alone. The authors recommended studying the exposed workers for
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possible delayed effects and also described engineering control measures to 
be used to lower the exposure concentration below the existing TLV [66] of 
0.5 mg/cu m  for vanadium.
Since only 67 of 75 air samples were reported, it is not possible to 
verify the mean value for vanadium of 0.844 mg/cu m quoted by the authors 
[36]. Methods of sampling and analysis were not given in detail.
Lewis [25], in 1959, studied the effects of vanadium exposure on 24 
men, 38-60 years old, who had worked with vanadium at two locations 
(Colorado and Ohio) for at least 6 months (average employment 2.5 years) 
and presumably had not been exposed to any other metals. All but one 
vanadium concentration were less than 0.38 mg/cu m. Forty-five men of the 
same age range, economic status, and job-related activities as the vanadium 
workers were selected at random as controls from an area near the two 
plants (22 in one location, 23 in the other) . Each of the men received a 
complete physical examination, which included medical and work histories, 
electrocardiogram, urinalyses (routine and for vanadium content), 
hematocrit determination, and serum cholesterol analysis. A standardized 
history form was used, and all histories and physical examinations were 
completed by one observer. Air samples were taken in both plants by 
collecting dusts on millipore filters using calibrated air pumps. Analysis 
for vanadium in both the dust and urine was carried out by the colorimetric 
method of Talvitie [55] using 8-quinolinol. Particle size measurements 
were also performed on each dust sample.
Significant differences were found by Lewis [25] in the symptoms and 
physical findings of the exposed workers and controls. Eye, nose, and 
throat irritation, productive cough, and wheezing were the most significant
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symptoms, while congestion of the pharynx, green tongue, rales, and rhonchi 
were the most significant physical findings. In almost one-half of the 
workers who had a cough, it was of a productive nature. The author stated 
that the signs of bronchospasm from inhalation of vanadium could persist 
for 2-3 days after cessation of exposure and could mean that particulate 
vanadium was present in the respiratory tract during the same time period. 
Another possibility was that the smooth muscle contraction was maintained 
by mechanisms other than direct chemical irritation. The color of the 
tongue, of no toxicologic importance but a sign of vanadium exposure, 
varied from pale green to dark greenish-black depending on the atmospheric 
concentrations of the vanadium compounds (vanadates and vanadium 
pentoxide). The mean concentrations of vanadium found in the urine of the 
controls and of the exposed workers were 11.6 and 46.7 /ug/liter, 
respectively. Air analyses showed that the maximum air concentration was 
0.925 mg/cu m  of vanadium (as vanadium pentoxide), and the remaining 
concentrations were less than 0.38 mg/cu m  (range 0.38-0.018 mg/cu m) with 
97% of the particles less than 5 f m  in size. There were no significant 
differences in the results of the electrocardiograms, hematocrits, and 
clinical urinalyses of the exposed and control groups.
Lewis [25], comparing his study with four others [24,26,63,67], 
considered the reasons for the differences noted, and concluded that there 
was no evidence of chronic intoxication or injury attributable to vanadium 
exposure. However, in view of vanadium's known respiratory effects, he 
suggested it was important to exclude persons with arrested tuberculosis or 
chronic lung diseases from exposure to vanadium dust.
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In 1955, Vintinner et al [67] conducted environmental and medical 
studies of 78 workers engaged in the processing of vanadium-bearing ore and 
of 37 control workers. The controls (median age 25 years) were employed by 
the same company in occupations where there was no exposure to vanadium. 
Half of the 78 workers (median age 27 years) were exposed to dust from the 
ore before roasting (inactive ore), and the other half (median age 32 
years) were exposed to vanadium ore after roasting (active ore) and to the 
final product of vanadium pentoxide. All dust particles were less than 5 
pm in diameter. About two-thirds of the men in the exposed and control 
groups had been employed less than 3 years. In all three work areas, a 
total of 105 air samples and 15 material- and settled-dust samples were 
collected and analyzed for vanadium concentration; 20 air samples also were 
taken to determine the sulfur dioxide content of the air. Air was sampled 
at each work location at random times on different days in each plant over 
a period of 3 weeks. Duration of sampling was 20-40 minutes in vanadium 
exposure areas and about 2 hours in control group workplaces. 
Occupational, personal, and medical histories, as well as chest 
roentgenograms and analyses of urine and blood samples, were conducted. 
The vanadium content of all air, blood, and urine samples was determined by 
the method of Talvitie [55] using 8-quinolinol.
Sulfur dioxide concentrations ranged from nondetectable to 2.0 ppm, 
an insufficient amount to cause irritation according to the author [67]. 
Air concentrations of vanadium were 0.01-2.12 mg/cu m in the inactive ore 
area, and 0.77-58.8 mg/cu m  (average 12.77 mg/cu m) and 0.02-1.10 mg/cu m 
in the active ore areas.
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Exposed workers compared to controls had significantly higher 
incidences of several signs and symptoms indicative of irritation to the 
upper respiratory tract and eyes. Numerous other signs and symptoms were 
reported in the exposed group, such as palpitations on exertion, night 
sweats, pneumonia, tiredness, and increased corneal vascularization. The 
authors indicated that these Peruvian workers had an "elevated" use of 
alcohol, tobacco, and coca. In addition, the mines were located at 
altitudes of about 14,000 and 15,000 feet, so it is conceivable that drug 
use and hypoxia contributed to the observed effects; however, drug use and 
working and living altitudes did not differ significantly between workers 
and controls. The exposed workers showed no significant differences from 
the controls in the laboratory tests, except for the vanadium content of 
the urine. The highest values in the urine of the control group, inactive 
ore group, and active ore group were 0.060, 0.110, and 0.298 mg/liter,
respectively.
Animal Toxicity
The animal experiments described in the following discussion were 
selected to reduce repetition of the effects described in the previous 
sections. Included in this section are studies that offer evidence as to 
the mode of toxicity of vanadium and its compounds and other effects that 
have not been demonstrated in humans.
Roshchin [41,68] carried out three series of experiments on the long­
term effects of vanadium aerosol on white rats of unreported age, sex, and 
weight. In the first series, 20 white rats were enclosed in a chamber (not 
described) where they inhaled a condensation aerosol of vanadium pentoxide
at a concentration of 3-5 mg/cu m for 2 hours every other day for 3 months.
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The aerosol was obtained by heating vanadium pentoxide in the flame of a 
Volta arc. In the second series, 15 white rats inhaled an aerosol of 
vanadium pentoxide (generated by grinding) at a concentration of 10-30 
mg/cu m for 1 hour/day for 4 months. In the third series, 15 white rats 
inhaled ferrovanadium dust at a concentration of 1,000-2,000 mg/cu m of air 
for 1 hour every other day for 2 months.
On extended inhalation of vanadium pentoxide, apparently in the first 
two series, the rats became emaciated and passive, and there was a 
discharge from the nose, said to be hemorrhagic, but probably a porphyrin, 
from the Harderian gland [41,68]. The rats exposed to ferrovanadium dust 
had no outward signs of poisoning during the 2-month period. The body 
weights and behavior of these animals did not differ from those of the 
controls. Microscopic examination of tissues of all the rats killed after 
the termination of the experiment showed only changes in the lungs, which 
were signs of marked irritation of the respiratory mucosa and injury to the 
lining of the blood vessels, resulting in stasis and increased permeability 
of the capillaries, producing perivascular edema and hemorrhages. The 
investigator did not report whether these lung changes were from 
ferrovanadium, vanadium pentoxide, or both. Also a spastic effect on the 
smooth muscle of the bronchi (bronchospasm) was evident, which may explain 
the development of an asthmatic type of bronchitis and of expiratory 
difficulty observed in the case of short-term poisoning. Roshchin 
mentioned the effects of absorption of vanadium, ie, high concentrations 
led to focal hemorrhages or congestion of the vessels of the internal 
organs and the brain, and that these effects may also have explained the 
neurologic signs, toxic nephritis, and the disorders (unspecified) of
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protein metabolism encountered in his previously performed short-term 
studies [41,68], There were several weaknesses in this report. The number 
of rats that had lung changes was not given, and although controls were 
mentioned, no other facts about them were presented. No statistical data 
were available and the analytical method for determining the air 
concentrations of vanadium was not given. Some of the changes observed, 
such as hemorrhages, may have been agonal rather than a reflection of 
vanadium toxicity.
Roshchin et al [35], in 1965, studied the toxic effects of vanadium 
trioxide dust inhaled 2 hours/day for 8-12 months on 18 male rabbits 
weighing between 2.7 and 3.3 kg. There were nine control animals. Of the 
18 experimental rabbits, 13 were exposed for 2 hours daily in a chamber in 
which the vanadium trioxide dust concentration was 40-75 mg/cu m, and 5 
received vanadium metal at a dose of 5 mg/kg daily by mouth for 5.5 months. 
After 1.5 months, attacks of difficult and rapid breathing with nasal 
discharge were observed in five rabbits that inhaled vanadium trioxide, but 
the animals usually returned to normal within 4-5 hours after their removal 
from the chamber. However, these rabbits died at the height of one of the 
attacks. At the end of the testing period, the surviving experimental 
rabbits showed reductions in body weight (4.6% loss; controls gained 
12.3%), leukocyte count (in spite of normal erythrocyte count), hemoglobin 
value (fell from 75 to 67.8%), vitamin C content of the blood, serum 
protein sulfhydryl group value, and tissue respiration activity in liver 
and brain tissue. Blood cholinesterase activity increased by an average of 
25%. No changes were noted in the rabbits' behavior, erythrocyte count, 
total protein content, ratio of protein fractions of blood serum, or
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respiratory quotient. The author stated that an allergic effect of
vanadium trioxide must be considered, especially with the occurrence of
increased cholinesterase activity in animals; however, he did not elaborate 
on the connection between blood cholinesterase changes and allergy.
A characteristic feature of vanadium trioxide dust inhalation was the 
irritant effect [35]. Attacks of bronchial asthma from vanadium trioxide 
were said to have occurred in experimental animals, and the authors 
believed this showed that vanadium trioxide had an allergenic effect.
In 1966, Roshchin et al [69] studied the effects of ferrovanadium and 
vanadium carbide dusts inhaled at concentrations of 40-80 mg/cu m by white 
rats and rabbits of unstated age, sex and weight. Twelve rats inhaled 
ferrovanadium dust every day for 2 months, while 12 rats and 8 rabbits
inhaled vanadium carbide every day for 9 months. The duration of each
day's exposure was not given. Particle sizes ranged from 69 to 74% of less 
than 2 jum, and from 85 to 93% of less than 5 ¡ x m . Biochemical studies of 
the blood were conducted during the two experimental periods. At the end 
of the experiment, the animals were killed and their organs were examined
for abnormalities. One group of 10 rats and 10 rabbits was used as
controls, apparently for all experiments.
The rats and rabbits showed what the authors interpreted to be only
chronic conditions, such as catarrhal bronchitis, and moderate but 
widespread proliferative interstitial changes resulting in sclerosis and 
perivascular edema [69] . Roshchin et al noted that biochemical changes 
from chronic exposure to dusts of vanadium (unspecified form) and 
ferrovanadium were similar in nature, but they added that these were 
unstable, less clearly expressed, and statistically unreliable. The
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interstitial proliferative process in the lungs was more evident in rats 
than in rabbits. However, the degree of difference or the compounds 
involved were not presented. The authors concluded that the effect of 
vanadium on animals was the same, whether bound to carbon (vanadium 
carbide) or to iron (ferrovanadium and alloys). Overall, the paper is 
unsatisfactory from the standpoint of lack of data and clarity about 
details.
There appeared to be no statistically significant changes in the rats 
after inhalation of ferrovanadium, based on the data and statements as 
reported by Roshchin et al [69] . Roshchin et al did not give any 
indication of alveolar damage from ferrovanadium. They stated that 
sclerosis occurred, but not to any great extent. The impression is that 
the effects of ferrovanadium are reversible on cessation of exposure.
In 1966, Pazynich [70] performed two experiments to study the 
responses of rats to inhaled vanadium pentoxide at several concentrations. 
In the first experiment, lasting 70 days, 33 white male rats weighing 110- 
130 g were divided into 2 experimental groups and 1 control group; 11 rats 
were in each group. Groups 1 and 2 were exposed continuously for 24 
hours/day, 7 days/week, to vanadium pentoxide at concentrations, determined 
colorimetrically, of 0.027 and 0.002 mg/cu m, respectively; the controls 
were free from exposure.
All groups of rats were active and gained body weight [70] . In group 
1, during the experiment, the motor chronaxy of the extensor muscles 
decreased, the chronaxy of the flexor muscles increased so that the normal 
ratio was altered, which the author interpreted as a change in the CNS 
caused by the highest concentration (0.027 mg/cu m ) . The percentage of
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leukocytes with altered nuclei increased, and the oxyhemoglobin content in 
the venous blood was reduced. Measurements taken 20 days after the 
experiment ended were the same as the initial values. Blood cholinesterase 
activity in group 1 decreased during the experimental period and 90 days 
thereafter, but there were no changes in groups 2 and 3. The total protein 
of the blood serum increased in groups 2 and 3; however, it was reduced in 
group 1. Protein fractions of blood serum showed increased gamma globulins 
and decreased beta globulins in group 1. The author reported that, 20 days 
after the experiment, no significant differences were noted in protein 
fractions of groups 2 and 3, although no initial values or experimental 
values were reported for these groups. Liver tissue of group 1 placed in a 
Warburg apparatus absorbed 24% more oxygen than controls (P<0.05). There 
were no reliable differences in groups 2 and 3. Microscopic study of 
tissues showed that only group 1 had abnormal changes. The lungs showed 
vascular congestion, focal hemorrhages, and indications of bronchitis. The 
liver displayed acute vascular congestion in the central veins, 
accumulation of leukocytes in portal areas, and granular dystrophy of the 
hepatic cells. The kidneys showed granular dystrophy and some necrosis of 
the epithelium of the convoluted tubules, and the myocardium had congested 
blood vessels surrounded by focal hemorrhages. Rats that inhaled vanadium 
pentoxide at a concentration of 0.002 mg/cu m (0.001 mg/cu m  as vanadium) 
for 70 days showed no toxicologic changes.
In the second experiment, lasting 40 days, a group of 10 young male 
white rats of unspecified weight was exposed continuously for 24 hours/day, 
7 days/week, to vanadium pentoxide at 0.006 mg/cu m, and an identical 
control group was unexposed [70] . Chronaxy of the antagonist muscles in
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the rear leg, leukocytes with altered nuclei, plus the general condition 
and weight changes of the rats were all evaluated using the same techniques 
as in the first experiment.
After 30 days, reliable changes (P<0.05) occurred in the ratio of the 
chronaxy of antagonist muscles in the experimental rat group versus those 
of controls [70]. On the 6th week of exposure, all rats were given water 
alone. After both groups were not fed for 3.5 days, rats in the 
experimental group showed significant (P<0.001) changes in the relationship 
of chronaxy of extensors to flexors in the rear leg; it was the reverse of 
the normal (index— 0.92). There was a reliable increase by a factor of 
4.83 in abnormal nuclei of leukocytes (P<0.005) in exposed rats in 
comparison with the controls. The animals' weights and general conditions 
were not reported.
Pazynich [70] concluded from the two experiments that vanadium 
pentoxide inhaled continuously at a concentration of 0.027 mg/cu m for 70 
days significantly affected the rats and produced morphologic lesions in 
the liver, kidneys, and lungs; that a concentration of 0.006 mg/cu m 
vanadium pentoxide inhaled for 40 days influenced the rats only after the 
animals had been starved for 3.5 days; that vanadium pentoxide inhaled 
continuously for 70 days at a concentration of 0.002 mg/cu m had no effect 
on the rats, and that, based on these findings, the daily mean maximum 
permissible concentration of vanadium pentoxide in the atmosphere (probably 
for community air) should be set at 0.002 mg/cu m. He did not present his 
reasons for assuming that rats and humans were equally susceptible to 
vanadium poisoning.
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In 1967, Kanisawa and Schroeder [71] studied the incidences of tumors 
in mice of both sexes given vanadyl sulfate during their lifetimes. 
Random-bred white Swiss mice, of the Charles River strain, were given from 
20-22 days of age until death, doubly deionized water containing essential 
trace metals: manganese (10 /¿g/ml) , chromium (1 /ig/ml), cobalt (1 jug/ml),
copper (5 ¿¿g/ml) , zinc (50 ¿ug/ml), and molybdenum (1 pg/ml) as the acetate, 
citrate, or molybdate. Groups of 23-71 of each sex, randomly selected from 
the litters, were given additional elements at 5 n g  of metal/ml of water, 
eg, vanadyl sulfate. The diet contained 3.2 jug of vanadium/g of feed. 
Dead mice were weighed and 542 were necropsied. Tissues of 433, considered 
abnormal, were fixed in Bouin's solution, sectioned, and stained with 
hematoxylin and eosin. Microscopic examinations were made on the heart, 
lungs, kidneys, liver, spleen, and any other organs that appeared abnormal 
or had a visible tumor. The data presented only represented tumors visible 
under a magnifying lens. Numerical data were treated by chi-square 
analysis and by Student's t-test. Pretumorous lesions of the liver and 
lungs were designated as growths of atypical parenchymal cells lacking in 
proper stroma, which replaced normal epithelial cells in the bronchi, 
alveoli, or hepatic sinusoids. Benign tumors were considered to be 
autonomous growths of well-differentiated cells that might be slightly 
atypical, but which did not metastasize to other organs or in the organ of 
origin. Sections of tissue were analyzed microscopically depending on the 
presence of cell clusters in the lungs and liver appearing pretumorous; of 
circumscribed benign adenomas, carcinomas, sarcomas, or lymphomas; 
leukemias; and other tumors benign and malignant in lungs, liver, mammary 
glands, and other locations. As no significant differences appeared
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between incidences of tumors in the two sexes, they were grouped together.
Of 170 controls that died within a 33-month period, 40 had benign 
tumors and 15 had malignant tumors, at a total tumor incidence of 32.4% 
[71]. No autopsies were performed on 28 of the 170 controls. Twenty-nine 
of the 40 benign tumors were adenomas, 20 of the lungs, 7 of the liver, and 
2 of the mammary glands; the remaining 11 benign tumors included 3 
lymphomas and 8 specified as "other." Of the 15 malignant tumors, 6 were 
found in the lungs and 5 in the mammary glands, and 2 were classified as 
leukemia and lymphoma. Of 47 vanadium-fed mice that died, 6 had benign 
tumors and 9 had malignant tumors, at a total tumor incidence of 32%; 5 of 
the 47 were not autopsied. Five of the six benign tumors were adenomas, 
four of the lungs, and one of the liver, and the remaining one being 
specified as "other." Of the nine malignant tumors, four were of the 
lungs, one of the mammary glands, three were classified as leukemia, and
one as "other." The mice receiving vanadyl sulfate did not exhibit a
significantly different incidence of tumors based on the total number of 
animals autopsied at the end of 33 months. The highest death rates for the 
autopsied mice occurred during 15-24 months of age, and, at this time, 113 
controls and 34 vanadium-fed mice were autopsied and showed 39 (34.5%) and 
11 tumors (32.4%), respectively. Examined sections of 141 controls showed 
62 with pretumorous lesions and 55 with tumors, 15 of the 55 being 
malignant. Of 38 examined sections in the vanadium group, 16 had
pretumorous lesions and 15 had tumors, 9 of these malignant. There was no 
weight difference between vanadium-fed mice and controls at all ages.
No evidence was presented in this study which suggested that vanadium 
influenced the incidence of tumors [71]. The diet, however, was
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unavoidably high in vanadium, although fairly low in other metals studied, 
causing the investigators to question the significance of the data. If the 
dietary vanadium was introduced mostly from milling machinery containing 
steel, it seems probable that the resultant vanadium would not be readily 
absorbed. The intake of water was calculated roughly at 7 ml / 100 g of body 
weight/day, which means about 35 pg of vanadium/100 g/day or about 13 
mg/100 g/year were consumed. The ingestion of 6 g of food/100 g of body 
weight/day would supply an additional 19.2 Mg of vanadium/100 g of body 
weight/day. The yearly total for both food and water, then, would amount 
to 19.8 mg of vanadium/100 g of body weight. Kanisawa and Schroeder [71] 
estimated that this dietary intake was about 17-29 times that measured for 
a 70-kg man in normal vanadium consumption.
Other studies by Schroeder and coworkers [72-74] using essentially 
the same procedures involving mice and rats showed the same results as the 
above study [71], ie, vanadium was not found to be carcinogenic at a level 
of 5 ppm (5 /ig/ml), as vanadyl sulfate, in drinking water after lifetime 
ingestion.
Franke and Moxon [75], in 1937, studied the toxic responses and 
hemoglobin values in rats fed vanadium as sodium metavanadate. Two groups 
of 10 young male and female albino rats (Wistar Institute strain), each 
appearing to be about 30-40 g by the authors' growth curves, were given 25 
or 50 ppm, respectively, of vanadium as sodium metavanadate in special 
wheat diets for 100 days. Two control groups of 10 rats each were given 
the same diet without vanadium. The rats were kept in individual draw 
cages and weighed at 5-day intervals throughout the experiment. Hemoglobin 
determinations were made on each rat on the 1st day and 6-10 times during
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the course of the experiment. Blood was drawn from the tip of the tail and 
hemoglobin values were determined by the method of Franke and Potter [76]. 
On the 100th day, the rats were killed and examined for gross lesions.
Franke and Moxon [75] found vanadium to be slightly toxic when fed to 
rats at 25 ppm, in that the growth rate was less than that of controls, 
although the treated rats ate more. Vanadium was distinctly toxic at 50 
ppm, at which level diarrhea occurred. However, the ingestion of sodium 
metavanadate had no definite effect on the hemoglobin values of the rats. 
Macroscopic necropsies were performed but not reported. Longer periods of 
feeding would have increased the value of this study, as would more 
information about the possible toxic effects observed.
Romoser et al [77], in 1961, studied the toxicity of vanadium as 
calcium vanadate in growing chicks. Phosphate supplements containing 
vanadium can be found in rocks and colloidal clays and could possibly be 
used as animal feed; thus, three experiments were used to determine the 
effects of vanadium on the performance of the growing chick. In the first 
experiment, four replicate groups of 13 male chicks, housed in brooders, 
were fed a basal ration (already containing 3 ppm of vanadium) with 40-600 
ppm of vanadium added for 11-32 days. In the second and third experiments, 
the authors used three replicate groups of 25 male Vantress x Arbor Acre 
crossbred broilers housed in floor pens. The second experiment entailed
the use of a commercial broiler starter ration with 10-40 ppm of vanadium
added for 7-28 days. In the third experiment, the authors fed chicks the 
same basal diet as in the first experiment but with 21-42 ppm of vanadium
added to the diet for 9-30 days. All experiments had control groups
containing the same number of chicks as the vanadium group that were fed
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diets without added vanadium. The rations and water were consumed at will 
and body weight gains and feed-conversion measurements were made at the end 
of each experiment period.
In the first experiment, 40 ppm of vanadium (lowest concentration 
added) depressed the rate of weight gain and efficiency of feed utilization 
of the chicks [77], All vanadium concentrations less than 200 ppm 
depressed growth rates and efficiency of feed utilization, while at greater 
than 200 ppm, all of the chicks died by the end of the experimental period 
(11-32 days). In the second and third experiments, the authors found that 
vanadium at concentrations up to 20 ppm could be tolerated, but, at 30-42 
ppm, progressively greater effects were obtained (lowered rate of weight 
gain and efficiency in the feed utilization). Growth was significantly 
(P=0.05) depressed from the addition of 30 ppm of vanadium to the basal 
ration, and, at 40 ppm, vanadium feed conversion was also significantly 
depressed.
Romoser et al [77] suggested that the endogenous vanadium content of 
rock phosphate supplements be below a concentration that would supply less 
than 30 ppm to a practical diet designed for broiler strain chickens; also, 
that the vanadium concentration in the rations should be below 3 ppm to 
protect the health of chicks, based on the three experiments.
In 1936, Franke and Moxon [78] determined the minimum fatal doses of 
vanadium as sodium metavanadate in 46 young Wistar strain rats of 
unspecified sex weighing 125-175 g. The vanadium was injected 
intraperitoneally (ip) and a wide range of doses (4.0-40.0 mg/kg) was used 
to determine the minimum fatal dose, defined as the dose that would kill at 
least 75% of the animals within 48 hours. The rats which were administered
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vanadium at large doses usually died of asphyxiation, while rats receiving 
smaller doses became comatose prior to death. The minimum fatal dose range 
was 4.0-5.0 mg/kg.
In 1953, Dalhamn et al [79] described the toxic effects of vanadium 
(as ammonium metavanadate) on 16 white mice, its effect on the blood 
pressure and respiration of 12 rabbits and 4 cats, and the use of 
dimercaprol (BAL) as an antidote for vanadium intoxication. Sex, age, 
strain, or weight information were not given for the experimental animals. 
Groups of 16 mice were injected subcutaneously with vanadium and 8 of these 
were immediately injected ip with BAL at 40 mg/kg. Small unspecified doses 
of ammonium metavanadate were given at first, then increased until the 
groups in the two series showed 100% mortality at 10 days after dosing.
A second experiment was conducted to test the effects of vanadium on 
blood pressure and respiration, both alone and in combination with BAL in 
the 12 rabbits and 4 cats [79].
In mice, the LD50 for vanadium alone was 20.4 mg/kg and 21.9 mg/kg 
with BAL. All eight mice survived when only BAL was injected by vein at a
dose of 40 mg/kg. Intravenous injections of vanadium at doses of 0.2 or
0.4 mg/kg reduced the arterial blood pressure and increased the respiratory 
frequency, while reducing the amplitude, in the rabbits and cats. When BAL 
at doses of 25-40 mg/kg was injected before vanadium at doses of 0.2 or 0.4 
mg/kg, there was a rise in arterial blood pressure instead of a fall. The 
respiratory effects on rabbits appeared to have been unchanged by BAL, 
while in cats, similar results or just a slight change in respiration were 
seen. There were no controls and no details were given as to what other
toxic effects the injections of vanadium and BAL produced.
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Biochemical and pharmacologic effects of vanadium, to the extent now 
understood, seem not to contribute to the derivation of an occupational 
health standard, and are not reviewed here.
Other reviews [59-61] have suggested that vanadium can inhibit 
synthesis of cholesterol and other lipids, activities of coenzymes A and Q, 
and several enzymes.
Correlation of Exposure and Effect
Exposure to vanadium and its compounds occurs primarily by inhalation 
or by contact with the skin or eyes. Human response to inhalation of 
vanadium compounds has been well documented and includes acute upper 
respiratory irritation with mucous discharge, and lower respiratory tract 
irritation with bronchitis [22,23,36,63,65], bronchospasm [19,25,36], and 
chest pain [24,30,36,63,64]. Other effects include discoloration of the 
tongue [20,24,25,28,30,34,36,56], contact dermatitis [19,23,26,30,36], and 
conjunctivitis [17,19,20,23,25,26,36,63,64,67]. Acute respiratory irrita­
tion has resulted from inhalation of vanadium-containing dusts and fumes at 
reported concentrations of 0.1-85 mg/cu m. At the higher concentrations in 
this range, irritation has been more severe and has almost always included 
the eyes, nose, throat, and bronchi.
Employees wearing filter masks and working at airborne vanadium 
pentoxide concentrations of 17.2-58.6 mg/cu m all experienced chest pains 
and coughing, sometimes spasmodic or productive [28]. Lower concentrations 
of sodium metavanadate, ammonium metavanadate, pure vanadium pentoxide, and 
vanadium ores, ranging from 3.6 to 25.1 mg/cu m, also produced respiratory 
tract irritation with coughing, sneezing, and minor nosebleeds [17]. When
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exposed to europium-activated yttrium orthovanadate at an average 
concentration of 0.844 mg/cu m (range 0.2-3.2 mg/cu m) , all of the well- 
known signs and symptoms of vanadium irritation were seen, though the most 
prominent respiratory effects observed were inflammation of the trachea and 
bronchi [36].
At concentrations of 1.0 mg/cu m or below, complaints were limited to 
coughing and throat irritation, again becoming less intense as air 
concentrations decreased [32] . Controlled exposure of humans to pure 
vanadium pentoxide at 1.0 mg/cu m produced persistent coughing, lasting 8 
days, but no other signs of irritation [32]. In 18 workers exposed to 
submicron particles of vanadium pentoxide and ammonium metavanadate at an 
average concentration of 0.25 mg/cu m  (range 0.08-0.76 mg/cu m ) , throat 
irritation and slight coughing were periodically observed [34]. Lewis 
[25], studying 24 workers exposed to vanadium pentoxide and vanadates at 
concentrations of 0.02-0.38 mg/cu m at 6 locations and 0.92 mg/cu m at one 
location, reported coughing, irritation of the nose and throat, and 
congestion of the pharynx as the most significant signs and symptoms. 
Interpretation of which concentrations in the range 0.08-0.76 mg/cu m [34] 
or in the range 0.02-0.38 mg/cu m [28] caused the irritant effects noted is 
not feasible because of the significant variation in concentrations found. 
However, the controlled human exposures performed by Zenz and Berg [32] 
allow such interpretation. These investigators [32] found that 8-hour 
exposures to vanadium pentoxide at 0.2 mg/cu m (0.1 mg V/cu m) produced, 
after 24 hours, a slight productive cough in five volunteers; no other 
irritant effects were noted. An 8-hour exposure of two volunteers at 0.1 
mg of vanadium pentoxide/cu m (0.06 mg V/cu m) only caused mucus formation
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within 24 hours. This mucus was easily cleared by slight coughing that 
lasted 3-4 days.
Most animal studies of vanadium toxicity have dealt with injected or 
oral doses. Of the few inhalation studies, most involved vanadium 
concentrations greater than 1.0 mg/cu m. Pazynich [70], however, described 
exposure of rats to vanadium pentoxide at concentrations of 0.002, 0.006,
and 0.027 mg/cu m. Motor chronaxy measurements, biochemical indices, 
weight, and general condition of the animals indicated that there were 
some, probably slight, effects at a concentration of 0.027 mg/cu m. 
Whether changes in blood and motor chronaxy are reliable indicators of 
toxicity is questionable. At a vanadium pentoxide concentration of 0.006 
mg/cu m, no changes in motor chronaxy or blood measurements were observed 
unless the animals were stressed by starvation for at least 3.5 days.
Other signs that often appeared after inhalation of vanadium 
compounds were wheezing, rales, rhonchi, and chest pains, but without signs 
of changes in ventilatory function. The appearance of these effects is 
difficult to correlate to exposure concentrations but the possibility of 
their presence should be recognized in cases of suspected overexposure to 
vanadium. Long-term exposures to vanadium compounds have resulted in signs 
and symptoms similar to those of short-term exposure, and the irritant 
effects were reversible on cessation of exposure. There have been reports 
of more severe changes such as emphysema and pneumonia; however, these have 
not been adequately correlated to occupational exposures because of the 
lack of data.
Whether or not chronic obstructive lung disease (emphysema) is a 
consequence of vanadium exposure is not so clear as is desirable for a firm
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conclusion. Some cases have been observed [24,64], but data on other 
possible causes in the populations, such as smoking, are not available. 
However, cases of bronchial asthma and bronchitis have been observed with 
sufficient frequency to warrant concern for decreased ventilatory function, 
and, possibly, a progressively decreased ventilatory function, on 
continuous exposure.
In addition to respiratory effects, ocular and dermal effects have 
been reported to result from contact with airborne vanadium compounds. 
Manifested primarily as a burning sensation or conjunctivitis, eye 
irritation occurs at concentrations as low as 0.018 mg/cu m  [25]. The 
concentration range reported by Lewis [25] was 0.02-0.92 mg/cu m with all 
but one concentration less than 0.38 mg/cu m. These were the lowest 
concentrations found to cause eye irritation. There have been no reports 
of permanent eye damage resulting from vanadium at any concentration.
Several authors have described irritation of the skin after exposure 
to vanadium dusts [19,26,30,36]. This irritation usually takes the form of 
a sensation of heat or itching, sometimes accompanied by rashes or 
eczematous lesions, and has been reported at airborne vanadium 
concentrations of 0.03-85 mg/cu m  [23,26,36]. Allergy may also be a factor 
in the occurrence of skin problems, since positive patch tests have been 
observed in a few cases of exposure [26,36]. Other compounds, such as 
caustic soda, sulfuric acid, or other corrosives, are commonly found in 
industrial environments, and may cause similar skin irritation when present 
in the workplace [23,26].
Although exposures to vanadium are primarily respiratory, ocular, or 
dermal, some oral contact may also occur, as shown by occasional reports of
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greenish-black discoloration of the tongue and oral mucosa of vanadium 
workers [24-26]. It appears that this sign is of no toxicologic importance 
[24-26] but is, in some cases, an indicator of the presence of vanadium 
compounds, and is at least cosmetically undesirable. Oral discoloration 
has occurred at reported concentrations as low as 0.08-0.76 mg/cu m 
(average 0.25 mg/cu m) [34], and it has often been accompanied by a salty 
or metallic taste. The discoloration disappears without further 
complication within 2-3 days after removal from exposure.
Many other nonspecific effects have been noted in workers exposed to 
vanadium compounds. Heart palpitations on exertion have been reported but 
have not been definitely linked to occupational exposure to vanadium. 
Fatigue has also been reported, but this was attributed to aggravated 
respiratory symptoms or shift work [26]. There were little or no effects 
on the gastrointestinal tract, kidneys, blood, and CNS, and there were no 
generalized systemic effects. No conclusive evidence of pneumonoconiosis, 
emphysema, or other chronic disease was found. Also, no carcinogenic, 
mutagenic, teratogenic, or reproductive effects of vanadium on humans or 
animals were found. There is conflicting evidence of whether or not there 
is a correlation of airborne vanadium concentrations with the vanadium 
content of postexposure urine samples.
Although the manufacture of ferrovanadium and vanadium-containing 
alloys consumes 80% of the vanadium produced yearly, there are few 
quantitative data to evaluate the reactions of humans exposed at low 
concentrations of these compounds. Roberts [20], reporting a review of 15 
years' experience at a ferroalloy plant, observed that vanadium metal, 
ferrovanadium, vanadium-aluminum, and vanadium carbide, all at unknown
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concentrations, resulted in only slight nose, throat, and respiratory 
irritation when the particle size was below 100-200 mesh (about 150 i m  and 
75 /im, respectively [21]). Unlike such vanadium compounds as the oxides or 
vanadates, ferrovanadium compounds have not caused the more severe signs 
and symptoms such as wheezing, rales, rhonchi, or chest pain.
Roshchin [41,68] reported no ill effects on rats exposed to 
ferrovanadium at 1,000-2,000 mg/cu m. However, he later reported that 
rabbits and rats exposed for 2 months to ferrovanadium and vanadium carbide 
dusts at 40-80 mg/cu m did not show signs of acute intoxication, but did 
show morphologic evidence of perivascular edema, bronchitis, and 
interstitial sclerosis.
Ferrovanadium compounds have not shown evidence of eye or skin 
irritation in humans or animals.
The effects of vanadium on humans and animals are summarized in 
Tables I1I-2, III-3, and III-4.
Carcinogenicity, Mutagenicity, Teratogenicity, and Effects on Reproduction 
There are no data in the available literature that show whether 
vanadium and its compounds are mutagenic or teratogenic. However, the 
carcinogenic potential of vanadium was tested by administering vanadyl 
sulfate at 19.8 mg of vanadium/100 g of body weight/year for the lifespan 
of white Swiss mice of the Charles River strain [71] . There was no 
evidence in this study that the ingestion of vanadyl sulfate influenced the 
incidence of tumors in the mice. Further studies of other vanadium 
compounds, of other species, and using other routes of exposure are 
desirable.
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Tab le  H I - 2
EFFECTS OF VANADIUM COMPOUNDS ON HUMANS
Duration and 
Substance Route of Exposure
Concentration 
















Respiratory irritation with 
bronchopneumonia, heart 
palpitations































Asthma in 3 of 120 workers
Bronchitis, fever, headache,
GI distress






























25 mg/d for 
2 wk, then 
125 mg/d for 
22 wk





SUMMARY OF EPIDEMIOLOGIC STUDIES WITH VANADIUM
Duration and Concentration






2.5 yr (mean) 
respiratory
0.5-16 yr 
6 yr (mean) 
respiratory
0.01-2.12 Eye, respiratory irritation
0.01-0.52 Respiratory irritation, 
discolored tongue












Eye, respiratory irritation, 63
chest pain, bronchitis, emphysema
Eye and respiratory irritation, 
bronchitis
T a b le  I I I - 4
EFFECTS OF VANADIUM COMPOUNDS ON ANIMALS
Duration and Concentration 






















2 hr/every 2d 























1 hr every 2 d 




3-5 mg/cu m Lung damage
0.027 mg/cu m Lung, liver, and heart changes;
blood changes
0.006 mg/cu m Motor chronaxy changes
0.002 mg/cu m No effects




30-200 ppm Reduced growth rate
10-20 ppm No effects
25-50 ppm Reduced growth rate,
diarrhea
5 mg/kg/d No effects
1,000-2,000 Peribronchitis, perialveolitis
mg/cu m

















Workroom studies indicate that vanadium concentrations as low as 0.01 
mg/cu m  have been detected [25,67] using less effective engineering 
technology than is available today. Quarterly sampling reports of one 
vanadium production plant show average vanadium concentrations of 0.04 
mg/cu m  (range 0.002-0.31 mg/cu m) at 20 locations throughout the plant 
[80], Both personal monitors and high-volume samplers were used in this 
plant, with subsequent analysis by the ferrous ammonium sulfate titration 
method [81] and flameless atomic absorption spectrophotometry. Precision 
of vanadium analyses was estimated by the users to be ±5%.
Another vanadium pentoxide producer submitted the results of 3 years 
of area sampling [82]. The first group of samples was taken before the 
installation of a new dust collection system. The results of these 89 
samples averaged 0.12 mg V/cu m. After installation of the new equipment, 
sampling was resumed and the average of 15 samples was 0.02 mg V/cu m. Air 
samples were taken from a 12,000-sq ft area, with a high-volume sampler, 
for 30 minutes at 40 cu ft/minute. Vanadium analysis was performed by the 
ferrous ammonium sulfate titration method [81]. The producer also reported 
that, at these vanadium concentrations, there were 8-10 incidents where 
employees complained of symptoms resembling those of the common cold, but 
lasting only 2-4 days.
N.E. Whitman reported the results of 30 breathing-zone samples taken 
in a steel plant [60]. The vanadium concentrations reported ranged from 
0.5 to 10.6 jug V/cu m, with one value of 43.6 n g  V/cu m. According to N.E.
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Whitman (personal communication, August 1977) the samples were analyzed by 
the method of Talvitie [55].
Table III-2 summarizes some environmental data, together with the 
effects of exposure at various concentrations and chemical forms of 
vanadium.
Air Sampling
Several methods have been used to sample airborne vanadium. An ideal 
method would collect all particles regardless of particle size and would be 
representative of the worker's actual exposure without restricting normal 
work activities.
The most frequently used collection devices are filters that may be 
made of paper, glass, polystyrene, or other polymers such as cellulose 
ester or polyvinyl chloride. Analytical filter papers such as Whatman 41 
have the advantage of low flow resistance, but, depending on face velocity, 
particles below 0.5 ¿cm may not be completely collected. Filters of glass 
or polystyrene fibers have higher collection efficiencies and are 
nonhygroscopic and, therefore, may be preferred over filters of cellulose 
fiber. Membrane filters, such as the Millipore AA or Nucleopore, are 
composed of polymers such as cellulose ester or polyvinyl chloride. These 
filters are usually highly efficient for collection of particles larger 
than the mean pore size, which can range from 0.01 to 5 / x m .  Collection of 
total airborne particulates would require a filter with a small pore size, 
usually 0.8 /¿m, which would provide essentially complete collection of
particles less than 0.5 / i m and of dust particles of larger sizes [83,84]. 
Membrane filters with larger pore sizes, up to 5.0 pm, may be used, but
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possibly with some loss in efficiency. The use of silver membrane filters 
for collection of vanadium-containing aerosols has not been studied, but 
they may be of value, provided they do not interfere with procedures 
involved in analysis. As described by Lippmann [85], they are made by 
sintering uniform metallic silver particles, and they have a structure 
similar to that of organic membrane filters.
Air sampling for worker exposure should be performed by personal 
sampling whenever possible. A personal sample can be taken for up to 8 or 
10 hours on a worker by using a battery-operated, belt-worn pump connected 
by rubber or plastic tubing to a membrane filter holder. Any known 
flowrate between 0.5 and 3 liters/minute is satisfactory. If both ceiling 
and TWA concentration exposures are to be assessed, repeated 15-minute 
samples may be best.
Other sampling devices such as electrostatic precipitators or high- 
volume area samplers may also be used for collection of airborne vanadium 
particulates. Electrostatic precipitators have the advantages of being 
free of filter clogging and problems with flowrate or humidity. These 
systems are also very efficient in collecting particles of all sizes. When 
electrostatic precipitators are used, however, special precautions must be 
taken to guard against electric shock. High-volume sampling is also 
appropriate for airborne vanadium collection, but the characteristics of 
the filter medium should be considered so that optimum collection 
efficiency is obtained. Like electrostatic precipitation, high-volume 
sampling suffers from the disadvantage that the actual employee exposure 
may not be estimated as closely as is possible with personal sampling.
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Chemical Analysis
Vanadium is readily determined by a number of analytical techniques, 
most of which are spectrophotometric or titrimetric. Other methods such as 
polarography [86], emission spectroscopy [87-90], X-ray fluorescence [91- 
96], and neutron activation analysis [97,98] may also be used, depending on 
the analyst's requirements for speed, accuracy, sensitivity, and precision. 
Spectrophotometric procedures are well suited to the determination of 
vanadium at low concentrations, because these procedures for vanadium are 
generally quite sensitive and relatively simple.
The widely used phosphotungstate method relies on the reaction of 
sodium tungstate with pentavalent vanadium to form a yellow complex which 
absorbs light at 400-450 nm and can be quantitatively estimated 
spectrophotometrically [99]. A similar complex, however, may also form 
between sodium tungstate and other metal ions such as iron, manganese, 
zirconium, bismuth, antimony and tin [100]. Interfering ions may be 
removed by mercury cathode electrolysis or by extraction of the sample 
solution with ethylmethyl ketone [101]. A phosphotungstate method, 
modified to exclude interference from other ions, has been reported for the 
determination of vanadium in samples from low-alloy steel [102].
Another spectrophotometric method is based on the measurement of the 
intensity of the magenta-black color of the complex formed from vanadium 
and 8-hydroxyquinoline in alcohol-free chloroform medium [55]. This method 
is especially suited for determination of 1-50 /ug of vanadium in samples 
from biologic materials. Iron must be removed from the same solution, 
since it is a strong interferent in this procedure. A masking agent such 
as ethylenediamine tetraacetic acid in the presence of a calcium salt is
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usually used for this purpose [55].
Titrimetric procedures have been successfully used for the 
determination of vanadium in steel and are based on the oxidation or 
reduction of the vanadium (IV) and vanadium (V) oxidation states. For 
sample solutions containing no oxidizable element other than vanadium, 
titrimetric analysis is very simple. An acidic solution of tetravalent 
vanadium is titrated with a standard permanganate solution. Pentavalent 
vanadium can also be titrated with a reducing agent, with results that are 
analogous to those obtained by titrating vanadium (IV) with an oxidizing 
agent. In principle, vanadium is oxidized to the pentavalent state, excess 
oxidant is destroyed, and the resulting solution is titrated with a 
standard solution of ferrous ions. The end points of either of these 
titrations may be determined visually, spectrophotometrically, 
potentiometrically, or amperometrically. Visual determinations are 
probably the least sensitive of these methods.
Excellent results have been obtained by Lingane and Meites [86] after 
polarographic analysis of a variety of steel and ferroalloy samples 
supplied by the National Bureau of Standards. Polarographic analysis of 
steel is possible only after removal of interfering substances such as 
molybdenum or manganese, either by the addition of phosphoric acid to the 
sample solution, or by electrolysis using a mercury cathode cell.
Samples obtained from air filters, alloys, and biologic material have 
been successfully analyzed by emission spectroscopy [87-89]. Excellent 
sensitivity is realized for this method, which gives a detection limit of 1 
fg of vanadium for some biologic samples [90]. The complex spectra of 
vanadium present many suitable lines for the detection of this element.
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Highly skilled personnel may be required to obtain and interpret spectra of 
high resolution and dispersion.
X-ray fluorescence spectroscopy is a convenient, precise, and 
relatively simple method for estimation of vanadium in biologic material 
[91], petroleum [92-94], steel alloys [95], and particulate matter filtered 
from the air [96]. Using X-ray fluorescence techniques, it is difficult to 
detect vanadium or any other metal if present in the sample at a 
concentration less than 100 ppm.
Very accurate and precise determinations of vanadium in particulate 
samples are possible using neutron activation analysis [97,98]. This type 
of analysis requires no chemical separations. Interferences, especially by 
sodium, are common because of simultaneous activation of many elements in 
the sample. These interferences may be reduced, however, if high 
resolution detectors are used. Standards are required that contain the 
same elements as the sample, at similar concentrations, and in the same 
containment geometry. Once activated, samples must be counted immediately, 
since even a 20-minute delay will cause a 97.5% reduction in vanadium 
activity. For air-filtered samples, a detection limit of about 1 ng, 
corresponding to a concentration limit of 2 ng/cu m, has been achieved 
[97,98].
Of all the analytical procedures discussed in the literature, atomic 
absorption spectrophotometry is the most commonly used for trace metal 
analysis because it is simple, rapid, sensitive, selective, and widely 
available. There are two main types of atomic absorption analysis: the
flame aspiration procedure and the flameless furnace-vaporization 
technique. Most metals can be determined by either procedure, though
8 6
interferences are fewer in the flameless mode. When using flameless atomic 
absorption for analysis of air-filtered vanadium samples, Quickert et al 
[103] found that interferences encountered in the conventional flame 
technique were absent, and that detection limits for vanadium were lowered 
by two orders of magnitude to the minimum detectable concentration of 0.25 
ng/cu m for an air sample of 2,000 cu m. In these analyses of 
ferrovanadium for vanadium content, they digested the alloy in a mixture of 
nitric and hydrofluoric acids.
Engineering Controls
Engineering design for operations and processes involving vanadium 
and vanadium compounds should be oriented toward controlling inhalation 
exposures and minimizing skin and eye contact with the dust. Properly 
designed and maintained ventilation systems should prevent dispersal of 
vanadium into the workroom atmosphere and its accumulation on surfaces, 
thus reducing chances of resuspension. These goals can be accomplished by 
the use of properly constructed and maintained closed systems operated 
under negative pressure. Where closed systems cannot be adequately 
designed or effectively used, local exhaust systems with collection hoods 
at potential contamination sources should be provided to direct airflow 
away from the employees' breathing zones into the exhaust system. These 
systems should be designed to remove dust in as concentrated a form as 
possible, with proper allowance for makeup air. Guidance for design can be 
found in Industrial Ventilation— A Manual of Recommended Practice [104], in 
Fundamentals Governing the Design and Operation of Local Exhaust Systems
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(ANSI Z9.2-1971) [105], and in NIOSH's Recommended Industrial Ventilation
Guidelines [106].
Since dust clouds of some metallic vanadium are potentially 
explosive, construction materials must be nonsparking and ignition sources 
must be eliminated. According to the National Fire Protection Association, 
the minimum explosive concentration of these dusts is 200 g/cu m  with an 
autoignition temperature of 500 C [107].
Ventilation systems require regularly scheduled inspection and 
maintenance to ensure effective operation. These inspections should 
include measurements of system function, such as airflow measurements at 
collection hoods, static pressure at branch ducts, or pressure drop across 
filters and fans. Whenever consecutive measurements show a trend toward 
deterioration, equipment maintenance is indicated. Evaluation of the 
effectiveness of the dust control system, by measurement of general 
workroom air, operators' breathing zone air, and potential contamination 
sources, should be performed whenever changes are made in the ventilation 
system or in the work operations or processes.
V. WORK PRACTICES
In the production and use of vanadium, good work practices, in 
concert with engineering controls, should aid in reducing concentrations of 
airborne vanadium dusts, fumes, and vapors. These measures should further 
aid in preventing ingestion of and skin and eye contact with vanadium.
(a) Storage, Handling, and Use
Special precautions should be taken when using, storing, or shipping 
vanadium oxytrichloride. Vanadium oxytrichloride is a light-yellow liquid 
that decomposes to vanadium pentoxide and hydrochloric acid when exposed to 
moisture. The hydrochloric acid byproduct should be controlled so that 
exposures do not exceed the limit expressed in 29 CFR 1910.1000. Vanadium 
oxytrichloride should be stored in tightly closed, moistureproof containers 
in dry, well-ventilated areas away from heat or direct sunlight, and should 
be shipped in an inert atmosphere. Dry powder and carbon dioxide 
extinguishers should be used to put out fires that may occur near 
containers of vanadium oxytrichloride.
While vanadium does not pose a fire hazard, except for bulk 
quantities of finely ground metallic forms, and, so far as is known, is not 
a significant hazard when ingested, it is good practice to separate rest 
areas, eating facilities, and smoking areas from the work areas.
Vanadium carbide, vanadium-aluminum alloys, and vanadium metal 
itself, when ground smaller than 100 mesh (150 pm [21]) are considered by 
Roberts [20], on the basis of his 15 years' experience at a ferroalloy- 
production plant, to be combustible. This is also true of ferrovanadium 
ground smaller than 200 mesh (75 jum [21]). When present in bulk
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quantities, care should be taken to ensure that these finely ground 
products are kept dry and away from heat, sparks, or open flame.
Warning labels indicating skin, eye, and respiratory irritation 
hazards and urging use of adequate ventilation should be on containers used 
to transport various vanadium compounds, particularly fused flakes and fine 
granular ammonium metavanadate and vanadium pentoxide, trichloride, 
oxytrichloride, and tetrachloride. Placards should alert employees to the 
existence and nature of hazards, indicate the exit locations, and identify 
areas or situations where respirators or other protective items are needed.
(b) Maintenance of Equipment
The duties of maintenance and repair workers pose special problems 
with regard to the evaluation of their potential exposure. Often the very 
circumstances that require the maintenance or repair work and under which 
work must be done will negate some of the normal control procedures. 
Because of these factors, very careful supervisory control must be 
exercised over such activities. These workers should wear the appropriate 
protective equipment and clothing and should follow the standard operating 
procedures or directives from special work permits. They should be trained 
in the recognition and control of hazards to which they may be subjected.
(c) General Housekeeping
Where spills of vanadium dust, liquids, or solutions occur, the area 
should be posted to prevent entry by other employees and promptly cleaned 
up by means that will minimize inhalation of, or contact with, the 
materials. Vacuuming is preferred for spills of dry material along with 
wet mopping; no dry sweeping or blowing should be permitted. Liquid or 
wet material spills should be flushed with an abundance of water. The
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liquid waste should be channeled into a treatment system or into a holding
tank for reclamation or disposal. Process or storage areas where liquid
vanadium material is kept in large containers should be diked, and the
drainage of this liquid should be channeled into a collection area for
reclamation or disposal. Supervisors should emphasize to employees the 
necessity for prompt cleanup of spills, repair of equipment and leaks, 
proper storage of materials, proper functioning of dikes, and the prompt 
collection of vanadium-containing dust. All collected material generated 
by the processes should be recycled back into the process or disposed of in 
a manner that meets local, state, and federal regulations.
(d) Emergency Procedures
Safety showers and eyewash fountains should be located in or near 
areas where gross exposures to vanadium compounds are likely to occur and 
should be properly maintained. If vanadium compounds, especially the 
halide or oxyhalide liquids, come in contact with the skin, the affected 
area should be flushed promptly with water. The eyes, if splashed or 
otherwise contaminated with these reactive halides, should be flushed 
immediately and thoroughly with water at low pressure. The employee should 
then be taken promptly to the nearest medical facility to determine the 
need for further treatment. All employees should be fully informed of the 
need for carefully observing these procedures.
Although emergency procedures specific to hazards of vanadium and its 
compounds are not required, general emergency procedures should be 
developed. Training sessions should be held and complete written 
procedures for emergencies should be revised and updated periodically. 
They should include provisions for transportation of injured personnel to
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hospitals and the location, use, and maintenance of first-aid or 
firefighting equipment, emergency showers, and eyewash fountains. 
Emergency drills should be held at least once a year. All emergency plans 
should be designed to minimize personal injury, property damage, and 
process interruption.
(e) Respiratory Protection
Some industrial processes may produce simultaneous exposure to 
particulate vanadium and to vapors of such volatile liquids as some 
vanadium halides. In these areas, the employee should wear the recommended 
type of respirator that will provide protection against both particulate 
and vapor, and the employee should observe the practices of an established 
respiratory protective devices program. Cleanliness and maintenance of 
respirators should be emphasized. Contamination of the interior of the 
facepiece should be prevented. Detailed information concerning respirators 
is given in the Respiratory Protective Devices Manual, ANSI Z88.2-1969 
[108], and in the current federal standard, 29 CFR 1910.134. The proper 
respirators for protection against vanadium exposure are described in the 
Respirator Selection Guide in Tables 1-1 and 1-2.
(f) Skin and Eye Protection
Safety glasses with side shields and gloves should be issued to, and 
worn by, employees occupationally exposed to vanadium. Coveralls (which 
can be of the disposable type) should be worn to minimize the possibility 
of skin irritation. Rubber aprons or rubber suits and rubber gloves should 
also be worn in liquid vanadium compound areas, especially where there is 
production or use of vanadium oxytrichloride and tetrachloride, both of 
which are very irritating to the eyes, skin, and respiratory tract in
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either liquid or vapor form. While data demonstrating this irritation have 
not been found, it is reasonable to conclude that compounds so reactive 
with water and other materials, that thereby release heat and irritant 
materials such as hydrogen chloride, would necessarily be irritating to 
exposed tissue. Other personal protective equipment should be provided, 
used, and maintained as specified in 29 CFR 1910.132-137. The proper use 
of protective clothing requires snug, but comfortable, fit around the neck, 
wrists, and ankles whenever the wearer is in an exposure area. The
protective equipment and clothing must be maintained in good hygienic and 
uncontaminated condition and should be cleaned or replaced on a regular 
schedule. Employees should keep such equipment in suitable, designated 
containers or lockers provided by the employer when the equipment is not in 
us e .
Boiler cleaners should wear acid-resistant boiler suits that fit 
snugly at the wrists and ankles, rubber gauntlet gloves, and knee-length 
rubber boots. Eyes should be shielded by goggles, and a suitable
respirator should be worn; both goggles and respirator can be incorporated 
in a full-face mask which gives good protection. This should be worn with 
a suit with a hood to cover the neck and head. Alternatively, an air-fed 
hood to cover the head and shoulders may be used. Before entering, fire 
chambers must be purged with clean air and hosed down with water. Soot
should be vacuumed, rather than flushed with compressed air jet, so that
displaced soot is collected directly by a dust control system.
(g) Sanitation and Personal Hygiene
The employer should provide locker and change facilities for work and 
street clothes. Work clothing should not be worn outside the workplace to
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limit the possibility of exposure to the workshift, and so that family and 
friends are not potentially exposed. As a good practice, it is recommended 
that shower facilities, supplied with soap, be provided for the employees 
and that they be advised to shower before leaving the workplace at the end 
of the workday. Contaminated clothing should be removed and discarded or 
cleaned before reuse. Clothing to be reused should be stored in a 
container that is impervious to the compound. Personnel cleaning the 
clothing should also be alerted to the hazards of vanadium.
Good personal hygiene is important for the prevention of dermatitis, 
eye and respiratory irritation, and gastrointestinal problems from 
vanadium. It involves washing thoroughly before eating, smoking, drinking, 
or using toilet facilities.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1954, the American Conference of Governmental Industrial 
Hygienists (ACGIH) proposed threshold limit values (TLV) of 0.5 mg/cu m for 
vanadium pentoxide dust and 0.1 mg/cu m for vanadium pentoxide fume [109]. 
These TLV's were adopted in 1956 [18], and they referred to TWA
concentrations for an 8-hour work shift. Although no justification for the 
limit values was given at the time of publication, the information used to 
derive the values was provided in the 1962 edition of Documentation of 
Threshold Limit Values [66]. Roshchin [41,68] had earlier recommended 
limits for vanadium pentoxide dust and fume of 0.5 and 0.1 mg/cu m, 
respectively, based on limited animal experiments. The Documentation [66] 
stated that these recommended values were later substantiated by Stokinger 
in more extensive animal studies. Another study cited was that by Lewis 
[25], who found no toxic effects in humans exposed to vanadium dusts, 
including vanadium pentoxide, at concentrations of 0.1-0.3 mg/cu m. The 
ACGIH recommended a lower TLV for vanadium pentoxide fume than for the dust 
because of "the recognizedly greater toxicity of fume compared with dusts 
of larger size and smaller surface area."
The 1963 TLV for vanadium pentoxide dust was designated a ceiling 
limit not to be exceeded [110], and the TLV for vanadium pentoxide fume 
was designated a ceiling limit in 1964 [111], although the numerical values 
did not change. The 1971 edition of Documentation of Threshold Limit 
Values [112] cited a 1967 study by Zenz and Berg [32] that noted severe 
upper respiratory tract irritation in five humans exposed to vanadium
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pentoxide dust at a concentration of 0.2 mg/cu m for a single 8-hour 
period. They also found upper respiratory tract irritation, though not as 
severe, in two humans exposed to vanadium pentoxide dust at a concentration 
of 0.1 mg/cu m. Zenz and Berg [32] concluded that the TLV of 0.5 mg/cu m 
for vanadium pentoxide dust should be lowered. The Documentation also 
stated that Hudson [34] considered the standard for vanadium pentoxide dust 
too high because he found adverse effects in workers exposed at 0.25 
mg/cu m. The ACGIH did not lower the TLV for vanadium pentoxide dust. 
However, in 1972 [113], the vanadium pentoxide fume ceiling limit was 
reduced to 0.05 mg/cu m, based on the papers cited in the 1971 
Documentation. The ceiling limit designation was removed from the TLV for 
vanadium pentoxide dust, making it again a TWA concentration limit. A 
notation that vanadium pentoxide was to be expressed as vanadium was also 
added. No justification was given for these changes.
For ferrovanadium, the ACGIH proposed a TLV of 1.0 mg/cu m  as a TWA 
concentration in 1954 [109] and adopted this value in 1956 [18] . The
justification for this limit, provided in the 1962 edition of Documentation 
of Threshold Limit Values [66], stated that the only published information 
on which a limit could be based was from the USSR on exposed workers and on 
animal experiments. The Documentation cited the work of Roshchin [41,68] 
who found pathologic changes only in animals exposed to ferrovanadium dust 
at concentrations of 1,000-2,000 mg/cu m for 2 months. Chronic bronchitis 
and inflammation of the lungs were the pulmonary changes observed. Animals 
exposed at a concentration of 10,000 mg/cu m showed no acute intoxication. 
Roshchin recommended a limit for ferrovanadium of 1 mg/cu m. The ACGIH
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agreed that this value would provide a large margin of safety and adopted 
it as a TLV.
The report of the Sixth Session of the Joint ILO/WHO Committee on 
Occupational Health [114] listed maximum allowable concentrations of 0.5 
and 0.1 mg/cu m  for vanadium pentoxide dust and fume, respectively, for 
Finland (1962), Rumania (1966), USSR (1963), Yugoslavia (1964), and the 
Federal Republic of Germany (1966). The standards listed for vanadium 
pentoxide dust and fume for Hungary (1965) were TWA concentrations of 0.5 
and 0.1 mg/cu m, respectively. Rumania (1966), USSR (1963), and the 
Federal Republic of Germany (1966) listed a maximum allowable concentration 
of 1.0 mg/cu m for ferrovanadium. In addition to these standards, the 
ILO/WHO Committee reported maximum allowable concentrations of 0.5 mg/cu m 
for vanadium trioxide (sesquioxide) dust in the USSR (1963) and 0.1 mg/cu m 
for vanadium in Poland (1967). The bases for these were not described by 
the ILO/WHO Committee except for a statement that the limits for the 
Federal Republic of Germany were based on the 1966 edition of Documentation 
of Threshold Limit Values [115].
The present federal standard (29 CFR 1910.1000) for workplace 
exposure to vanadium pentoxide dust is a ceiling limit of 0.5 mg/cu m, 
based on the ACGIH TLV of 1968. The federal standard (29 CFR 1910.1000) 
for vanadium pentoxide fume is a ceiling limit of 0.1 mg/cu m, based on the 
ACGIH TLV of 1968, and not on the lower standard adopted by the ACGIH in 
1972. The present federal standard (29 CFR 1910.1000) for workplace 
exposure to ferrovanadium is a TWA concentration of 1 mg/cu m for an 8-hour 
work shift based on the 1968 ACGIH TLV.
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Basis for the Recommended Standard
(a) Permissible Exposure Limits
Occupational exposure to vanadium, especially vanadium pentoxide, 
produces mainly irritation of the eyes and of the upper respiratory tract, 
often accompanied by productive cough, wheezing, rales, chest pains, 
difficulty in breathing, bronchitis, questionable pneumonia, and rhinitis 
[17,19,24-26,39,47,64,65,67], There have been occurrences of green-to- 
black discoloration of the tongue, metallic taste, nausea, and diarrhea
[24.25.67], Six studies reported skin irritation [19,26,30,36,37,62], 
Similar effects on the skin and respiratory tract have been described in 
workers exposed to vanadium-containing byproducts of residual oil or crude 
oil combustion, gasification of fuel oil, and gas-turbine combustion 
[23,28,30,37,38,45,50,51], General fatigue, weakness, headache, and 
tremors of the hands have been reported [22,24,26,39,67] but their 
relationship to vanadium exposure has not been demonstrated. Earlier 
investigations [15,24] that suggested systemic poisoning effects from 
vanadium have not been confirmed by later and more detailed studies
[25.26.36.65.67] .
Examination of the literature has revealed that vanadium compounds 
such as the oxides and vanadates cause respiratory tract irritation, with 
possible eye and skin irritation. While there is no information on 
halides, it is reasonable to interpret, in part because they decompose to 
halide acids and vanadium oxides, that they will cause similar effects. 
Other forms of vanadium, eg, ferrovanadium, other alloys of vanadium, 
vanadium metal, and vanadium carbide are much less active toxicologically 
and cause lesser effects. Therefore, two categories of vanadium are
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proposed on which two standards should be recommended. Substances in each 
category produce essentially the same type of reaction, though the chemical 
form changes. Effects are typically of an acute or subacute rather than a 
chronic nature. There is some evidence of sensitization on repeated 
exposure [19,35]. Slight irritant effects were noted in two resting 
subjects exposed to vanadium pentoxide at a concentration of 0.06 mg V/cu m 
[32]. Since mild irritant effects followed exposure at 0.06 mg V/cu m for 
8 hours, a finding at least consistent with observations from several 
workplaces where exposures were approximated if not accurately estimated, 
it is evident that the environmental limit for vanadium pentoxide and some 
other compounds (vanadates, sulfates, halides, and other salts) should be 
lower. Experimental or epidemiologic data to demonstrate how much lower 
this limit should be are not available. A ceiling limit of 0.05 mg/cu m 
based on 15-minute sampling periods is proposed as a permissible limit 
pending the development of more definitive data that would justify a higher 
or lower value. A ceiling of 0.05 mg/cu m is probably equivalent in actual 
plant practice to a significantly lower TWA concentration, perhaps 0.01-
0.03 mg/cu m. As a consequence, the TWA corresponding to the ceiling is 
from one-sixth to one-half the 8-hour TWA concentration causing mild 
irritant effects in the subjects studied by Zenz and Berg [32] . This seems 
a reasonable factor to apply inasmuch as the adverse effects being 
considered are mild or slight. Inasmuch as the toxic actions of vanadium 
compounds are expressed largely, if not entirely, by irritant effects on 
the respiratory tract, it is likely that a ceiling concentration limit 
would be more appropriate as a control measure than a TWA concentration 
limit. This is based on the belief that irritant effects are usually
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proportional to exposure concentration, rather than to exposure dose (as 
approximated by a TWA concentration), or, in other words, are 
concentration-limiting rather than dose-limiting.
The current federal standard for vanadium pentoxide fume is 0.1 
mg/cu m. This form of vanadium is believed by many [62,116,117] to be more 
toxic than the dusts, which have a larger mean particle size. There have 
been no studies of human reaction to freshly formed vanadium pentoxide 
fume. Other metals, such as zinc, cadmium, or magnesium, form oxide fumes 
which, when inhaled, are known to be more toxic than the dusts, producing 
reactions such as chills, fever, and leukocytosis [118-120]. These 
reactions have not been reported for vanadium pentoxide when particle sizes 
are in the respirable range, ie, less than 5 ¿tm. NIOSH recommends, 
therefore, that the separate federal standard for vandium pentoxide fume be 
eliminated. NIOSH further recommends that vanadium pentoxide fume be 
considered a component of the "vanadium compounds."
There have been few quantitative data reported with which to evaluate 
the reactions of humans to air concentrations of ferrovanadium and 
vanadium-containing alloys. These metallic compounds appear to be almost 
toxicologically inert, though some slight acute respiratory irritation may 
occur if they are inhaled in sufficient quantity. Roberts [20] observed 
that exposure to vanadium metal, ferrovanadium, vanadium-aluminum alloys, 
and vanadium carbide, at unknown concentrations and particle sizes less 
than 200 mesh (about 75 jum [21]), resulted in slight nose, throat, and 
respiratory irritation. Roshchin [41,68] noted that rats exposed to 
ferrovanadium dust at concentrations of 1,000-2,000 mg/cu m showed no signs 
of acute effects. Microscopic examination of the lungs after 2 months of
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exposure indicated development of peribronchitis and perialveolitis and, in 
some animals, chronic inflammation of the lungs. He also reported that 
rabbits and rats exposed for 2 months to ferrovanadium and for 9 months to 
vanadium carbide at concentrations of 40-80 mg/cu m showed no signs and 
symptoms of acute intoxication, but did show signs of bronchitis and 
interstitial sclerosis. The existing federal limit of 1 mg/cu m  was 
originally based on studies [41,68] which are limited and of uncertain 
validity. It seems evident, however, that metallic forms like
ferrovanadium, alloys, and vanadium carbide have greater toxicity than 
would be expected from an inert dust. Thus, a limit lower than the inert 
dust limit of 15 mg/cu m is obviously needed, but not a limit as low as 
that proposed for vanadium compounds, ie, 0.05 mg/cu m. The existing 
federal limit of 1 mg/cu m  may be lower than is needed, but for worker 
protection it is proposed not to recommend a higher value until valid data 
are obtained. Thus, it is proposed to maintain the existing federal 
standard as a TWA concentration limit for up to 10 hours/day, for a 
workweek not exceeding 40 hours.
Vanadium compounds and metallic vanadium, when absorbed, are rapidly 
excreted and exhibit low degrees of toxicity, as indicated by minor 
irritation and lack of systemic effects. The action level is therefore 
defined as equal to the recommended environmental limit for each of the two 
proposed categories of vanadium.
(b) Sampling and Analysis
Personal sampling with a cellulose ester membrane filter is 
recommended, since most of the vanadium in the industrial environment 
exists as solid particulates and can be collected with 100% efficiency with
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this method [121]. Because there is no clear correlation between 
respiratory tract irritation and the particle size of vanadium that causes 
this effect, ie, both large and small particle sizes produce similar 
effects, total mass sampling is recommended instead of a respirable 
sampling method. It is not evident whether this sampling method will 
collect volatile vanadium compounds such as vanadium oxytrichloride. 
However, since they decompose in air to form vanadium oxide particulates, 
then much of the vanadium will be collected by the recommended procedure 
and, if the decomposition of the airborne halides is quantitative, all 
should be collected.
Flameless atomic absorption spectrophotometry is recommended for the 
analysis of vanadium, so that the necessary sensitivity and specificity can 
be attained. This method is free of interferences, fast, highly sensitive, 
and relatively simple.
(c) Medical Surveillance
Employees should be given preplacement medical examinations if a 
potential for occupational exposure to vanadium exists. Special emphasis 
should be directed to evidence of chronic eye or skin disorders and 
respiratory conditions or allergies, since exposure to vanadium may 
aggravate these or independently cause such effects. Because of cases of 
bronchial asthma and bronchitis in worker population exposed to vanadium 
compounds, periodic testing of pulmonary function is recommended. While 
the evidence that vanadium causes emphysema (reviewed in Chapter III) is 
not persuasive, neither can it be disregarded; periodic spirometry should 
detect chronic changes possibly leading to emphysema if this is a 
consequence of exposure to vanadium. The pulmonary or spirometric tests
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recommended are forced expiratory volume during the 1st second (FEV 1) and 
forced vital capacity (FVC). For similar reasons, roentgenograms are 
recommended. However, it is proposed that, except at preplacement 
examination, X-rays need not be performed routinely but at the discretion
of the responsible physician based on his knowledge of work exposure and 
clinical findings.
(d) Personal Protective Equipment and Clothing
Several investigators [19,26,30,36,37,62] have reported dermal and 
ocular irritation caused by vanadium compounds. The symptoms of 
irritation, consisting of itching or burning, were temporary and rarely 
accompanied by external lesions. Therefore, to minimize the possibility of 
skin and eye irritation, clothing resistant to the penetration of liquid 
vanadium compounds or solutions should be available and worn where 
indicated to prevent gross skin and eye contact. This clothing should
include boots, gloves, coveralls, face shields (8-inch minimum) with 
goggles, and safety glasses. Emergency showers and eyewash fountains
should be readily available in the event of accidental gross contact of the 
face or eyes with vanadium. In areas where engineering controls are not 
adequate to reduce exposure to limits set forth in this standard, 
respiratory protective devices should be used as delineated in Section 4(b) 
of Chapter I.
(e) Informing Employees of Hazards
Since exposure to vanadium can cause respiratory, eye, and skin 
irritation, employees who may be occupationally exposed to vanadium should 
be advised of the adverse effects from such exposure, of methods of
preventing exposure, and of surveillance procedures (environmental and
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medical monitoring) in use to detect, and thus to guide the control of, 
hazards.
(f) Work Practices
To minimize the possibility of respiratory contact with vanadium, 
engineering controls should be used when needed to control emissions to the 
work atmosphere. Such controls should include local exhaust ventilation 
for processes known to produce large amounts of airborne vanadium 
compounds. All vanadium containers should be closed tightly and stored 
properly when not in use to prevent breakage, spillage, or contact with 
moisture. Finely ground vanadium carbide, vanadium-aluminum alloys, 
vanadium metal, and ferrovanadium may be combustible and, thus, should be 
kept dry and away from heat, sparks, or flames. Spills or leaks should be 
attended to promptly. In case of emergencies resulting in gross skin or 
eye contact with liquid vanadium compounds or solutions, emergency showers 
or eyewash fountains should be available and used to clean affected areas. 
All employees, including maintenance and repair personnel, should be 
informed of all routine and emergency procedures for their specific jobs.
(g) Monitoring and Recordkeeping Requirements
So that airborne vanadium concentrations do not exceed the 
recommended environmental limits, a personal monitoring program should be 
instituted to collect airborne samples. Monitoring should be routinely 
performed every 3 months unless overexposure occurs, in which case, weekly 
monitoring should be conducted until successful control is achieved. 
Environmental monitoring and medical records should be retained for 30 
years after termination of employment involving exposures to vanadium, in 
keeping with the requirements of the Toxic Substances Control Act of 1976.
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V I I . RESEARCH NEEDS
Proper assessment of the toxicity of vanadium and evaluation of its 
potential hazard to the working population requires extensive human and 
animal studies. The following are aspects of epidemiologic and toxicologic 
research that are especially important.
Epidemiologic Studies
Further research is required to assess the effects of long-term 
occupational exposure to vanadium and its compounds, particularly the 
halides. Long-term epidemiologic studies should be performed and should 
consider pulmonary, skin, eye, and metabolic effects of vanadium. As a 
minimum, these studies should include medical histories, pulmonary function 
studies, environmental measurements, and other information such as 
histories of known or suspected exposures to vanadium compounds, including 
information on the specific compounds involved, and comparisons of 
morbidity and mortality data with those for a normal population.
Experimental Studies
Both short-term and long-term studies involving exposure to airborne 
vanadium at low concentrations should be conducted. Additional toxicologic 
experiments on a variety of species would further serve to characterize, 
both functionally and microscopically, the nature of any organ changes 
produced by vanadium, particularly the halides. Studies should use an 
exposure schedule simulating occupational exposure and should involve
105
routes of exposure that are likely to occur in occupational contact with 
vanadium (inhalation, ingestion, and skin contact) . These results should 
provide insight into human susceptibility to the effects of vanadium.
Carcinogenic, Mutagenic, Teratogenic, and Reproductive Studies
Studies on experimental animals should also be conducted to 
investigate the possibility of carcinogenicity, mutagenicity, 
teratogenicity, and effects on reproduction from absorption of vanadium 
compounds.
Sampling and Analysis
Sampling and analysis of vanadium halides and oxyhalides should be 
investigated. Studies of the kinetics of decomposition of these vanadium 
compounds may be necessary so that the adequacy of sampling and analytical 
methods may be evaluated.
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IX. APPENDIX I
The recommended sampling method for airborne vanadium is adapted from 
NIOSH Method No. S388 [121].
General Requirements
To evaluate conformance with the standard, collect breathing-zone 
samples representative of the individual worker's exposure. Record the 
following on all sampling data sheets:
(a) The date and time of sample collection.
(b) Sampling duration.
(c) Volumetric flowrate of sampling.
(d) Worker's name and job title and description of work station.
(e) Temperature and atmospheric pressure.
(f) Other pertinent information.
Apparatus
The sampling train for the collection of personal air samples has the 
following components:
(a) Filter: Mixed cellulose ester membrane filter with a pore
size of 0.8 f m ,  supported by a cellulose backup pad.
(b) Filter holder: 37-mm, 3-piece cassette filter holder.
METHOD FOR SAMPLING VANADIUM IN AIR
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(c) Personal sampling pump: Calibrated sampling pump whose flow 
can be determined to an accuracy of 5% at the recommended flowrate. The 
pump must be calibrated as described in Calibration of Sampling Trains.
(d) Miscellaneous: Thermometer, barometer, and stopwatch.
Calibration of Sampling Trains
The accurate calibration of a sampling pump is essential for the 
correct interpretation of the volume indicated. The proper frequency of 
calibration is dependent on the use, care, and handling to which the pump 
is subjected. Pumps should be recalibrated if they have been subjected to 
misuse or if they have just been repaired or received from a manufacturer. 
If the pump receives hard usage, more frequent calibration may be 
necessary. Maintenance and calibration should be performed on a regular 
schedule and records of these kept.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field, during field procedures, and after they have 
been used to collect a large number of field samples. The accuracy of 
calibration is dependent on the type of instrument used as a reference. 
The choice of calibration instrument will depend largely on where the 
calibration is to be performed. For laboratory testing, a soapbubble meter 
or spirometer is recommended, although other standard calibrating 
instruments, such as a wet-test meter or dry-gas meter, can be used.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be 
used. Since the flowrate given by a pump is dependent on the pressure drop 
of the sampling device, in this case a membrane filter, the pump must be
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calibrated while operating with a representative filter in line.
Calibration of the sampling train should be performed at a pressure of 1 
atmosphere.
(a) While the pump is running, check the voltage of the pump
battery with a voltmeter to assure adequate voltage for calibration.
Charge the battery if necessary.
(b) Place the preweighed membrane filter in the filter cassette.
(c) Assemble the sampling train according to the manufacturer’s 
specifications or as shown in Figure XII-1.
(d) Turn on the pump and moisten the inside of the soapbubble
meter by immersing the buret in the soap solution. Draw bubbles up the 
inside until they are able to travel the entire buret length without
bursting.
(e) Adjust the pump rotameter to provide a flowrate of 1.7
liters/minute.
(f) Start a soapbubble up the buret and measure with a stopwatch 
the time it takes the bubble to pass through a minimum of 1.0 liter.
(g) Repeat the procedure in (f) at least three times, average the 
results, and calculate the flowrate by dividing the volume of air between 
the preselected marks by the time required for the soapbubble to traverse 
the distance.
(h) Record the following calibration data: volume measured,
elapsed time, air temperature, atmospheric presure, serial number of the 
pump, date, and name of the person performing the calibration.
(i) Corrections to the flowrate may be necessary if the
atmospheric pressure or temperature at the time of sample collection
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differs significantly from those conditions under which calibration was 
performed. Where flowrates are read from rotameters or orifice meters 
only, the following formula may be used:
q = volumetric flowrate (liters/minute)
P = atmospheric pressure
T = temperature (degrees Kelvin or Rankine)
When wet test meters or bubble meters, etc are used to determine flowrates, 
the above formula should be used without the radical sign.
Air Sampling
(a) Collect samples as close as practicable to the employee’s 
breathing zone without interfering with the employee's freedom of movement.
Collect sufficient breathing-zone samples representative of worker 
exposure in each operation to permit calculation of each worker's TWA 
exposure. Sampling flowrates should be checked frequently. When filters 
become clogged so that airflow is too restricted, ie, when the flowrate 
drops below the design flowrate, change the filters and collect new 
samples.
(b) Collect samples using a portable sampling pump with a flowrate 
that can be determined to an accuracy of 5% at 1.7 liters/minute. Connect 
the pump to the filter unit, which consists of a membrane filter supported
where:
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by a cellulose backup pad mounted in a three-piece cassette filter holder.
(c) Operate the sampler at a known flowrate of 1.7 liters/minute, 
and record the total sampling time. A sample size of at least 25 liters is 
recommended.
(d) Seal the filter holder with the plugs provided and transport 
the cassette intact to the lab for analysis (see Appendix II).
(e) With each batch of 10 samples, submit 1 filter from the same 
lot used for sample collection, subjecting it to exactly the same handling 




Principle of the Method
(a) A  known volume of air is drawn through a mixed cellulose ester
membrane filter to trap the vanadium particles present.
(b) "Vanadium compounds" as defined in Chapter I are separated 
from the sample on the basis of their solubilities in a 0.01 N sodium 
hydroxide solution.
(c) Vanadium not dissolved by treatment with 0.01 N sodium 
hydroxide is "metallic vanadium" or vanadium carbide and is dissolved by
wet ashing.
(d) The solutions of samples and standards are analyzed by
flameless atomic absorption spectrophotometry (graphite furnace) with a
deuterium background corrector. A hollow cathode lamp for vanadium is used 
to provide a characteristic vanadium line at 318 nm. The absorbance is 
proportional to the vanadium concentration of the sample solution.
Range and Sensitivity
(a) Except for that portion of the method dealing with atomic
absorption analysis of vanadium pentoxide, this analytical method has not 
been evaluated by NIOSH or collaboratively tested; however it is 
recommended as an interim method pending further research.
(b) The detection limit for the determination of metallic vanadium
by atomic absorption has been reported as 1 ng/ml for a maximum sample
ANALYTICAL METHOD FOR VANADIUM
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injection of 100 y l  [103], This represents an absolute sensitivity of 0.1 
ng of vanadium.
Interferences
(a) There are no known spectral line interferences in this atomic
absorption assay for vanadium.
(b) Iron and molybdenum do not interfere with the atomic
absorption analysis for "vanadium compounds" even when present in the
proportion of 1 part of vanadium pentoxide to 10 parts of ferric nitrate or
sodium molybdate [121].
(c) Vanadium exhibits self-absorption at 318 nm. To minimize this 
absorption, it is necessary to operate the vanadium hollow cathode lamp at 
low currents.
Advantages and Disadvantages
(a) The method proposed for separating vanadium compounds from 
metallic vanadium is based on the alkaline solubility of the most 
frequently encountered and most widely used vanadium compounds. It may be 
that not all base-insoluble vanadium compounds can be included in the 
definition of "metallic vanadium", and that a few compounds, rarely 
encountered in industrial situations, may cause positive interference with 
analysis for metallic vanadium. One such compound, vanadium oxide (VO), is 
likely to be found with other vanadium compounds primarily in the vicinity 
of boiler-cleaning operations, areas where metallic forms of vanadium would 
be absent. In this case, the sum of the results of both alkali and acid 
treatments should best estimate total vanadium content of vanadium 
compounds in boiler soot.
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The proposed procedure, while not completely tested, appears to be 
the best method that can be recommended at this time for separation of the 
toxicologic classes of vanadium, ie (1) vanadium compounds and (2) metallic 
vanadium and vanadium carbide.
(b) The calibration curve is nonlinear above an absorbance of 0.9 
units, and in certain cases, depending on the graphite tube 
characteristics, it may be necessary to alternate samples with standards of 
similar response to obtain reliable results.
(c) It is possible that the precision and sensitivity of the 
method may be improved through the use of pyrolytic graphite tubes.
Apparatus
(a) Atomic absorption spectrophotometer having a monochromator
with a reciprocal linear dispersion of about 6.5 Angstroms/mm in the 
ultraviolet region. The instrument must have .a graphite furnace and a 
deuterium arc background corrector.
(1) Vanadium hollow cathode lamp.
Deuterium arc lamp.
Purge gases: argon (graphite furnace), nitrogen







(1) Beakers, 50-ml, with covers.
(2) Pipettes, delivery, 1, 5, and 10 ml and other 
convenient sizes for making standards.
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(3) Volumetric flasks, 10-ml, 25 ml, 1000 ml.
(4) Automatic microliter pipette.
(5) Polyethylene dropper.
(c) Water bath maintained at 50 C.
(d) Laboratory hotplate.
Reagents
All reagents used must be ACS Reagent Grade or better.
(a) Water, distilled or deionized.
(b) Sodium hydroxide, 0.01 N.
(c) Sulfuric acid, concentrated.
(d) Nitric acid, concentrated.
(e) Nitric acid, 1%(v/v)
(f) "Vanadium compounds" aqueous standard stock solutions
containing 100 jug V/ml prepared by dissolving 0.179 g of vanadium pentoxide 
in 0.01 N sodium hydroxide and diluting to 1.0 liter with 0.01 N sodium 
hydroxide.
(g) "Vanadium compounds" working standard solutions 0.1 to 1.0 n g
V/ml prepared by appropriate dilution of above solution with 0.01 N sodium 
hydroxide.
(h) "Metallic vanadium" standard stock solutions containing
lOOjug/ml, prepared by dissolving 0.100 g vanadium metal in a minimum volume 
of concentrated nitric acid, and diluting to 1.0 liter with 1% (v/v) nitric 
acid.
(i) "Metallic vanadium" working standard solutions 0.1 to 1.0




Before use, all glassware should be initially soaked in a mild 
detergent solution to remove any residual grease or chemicals. After 
initial cleaning, the glassware should be thoroughly rinsed with distilled 
water, soaked in dilute (1:10) nitric acid for at least 30 minutes, then 
rinsed with tap water followed by distilled water, and allowed to air dry.
(a) Open the filter container and carefully remove the membrane 
filter.
(b) Transfer the filter to a 50-ml beaker with the aid of filter 
tweezers.
(c) To ensure complete dissolution of the "vanadium compounds" 
from the filter, add 3 ml of 0.01 N sodium hydroxide to the beaker and heat 
in a water bath at 50 C for 30 minutes.
(d) Filter the sample solution through a 0.45-/um membrane filter 
into a 10-ml volumetric flask, rinsing the beaker twice with 1-2 ml 
portions of 0.01 N sodium hydroxide. After filtration, transfer the 0.45jum 
membrane filter to the beaker containing the original sample filter and 
reserve both filters for analysis of "metallic vanadium."
(e) Dilute the filtrate to 10 ml with 0.01 N sodium hydroxide and 
proceed to step (k), the analysis for "vanadium compounds." Steps (f) 
through (j) are for the analysis of "metallic vanadium".
(f) To the beaker containing the membrane filters add 12 ml of 
concentrated nitric acid (in 3-4 ml portions) and 1 ml concentrated 
sulfuric acid. Cover the beaker with a watch glass and heat on a 120 C 
hotplate until solution is complete. If insoluble material persists, 
stronger acid mixtures may be necessary [122] .
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(g) Evaporate to a volume of about 2 ml.
(h) Cool, and slowly add 5 ml 1% (v/v) nitric acid.
(i) Heat at 85-100 C until salts are dissolved.
(j) Quantitatively transfer the clear solution to a 25 ml
volumetric flask, and take up to volume with 1% (v/v) nitric acid. Proceed
to step (1).
(k) Analysis of "vanadium compounds": Inject 25 yul of the
resultant solution into the graphite furnace. Furnace parameters may vary 
among laboratories. Suggested parameters are: dry at 100 C for 20
seconds; char at 1100 C for 10 seconds; and atomize at 2,600 C for 15
seconds. Use the deuterium arc lamp to correct for matrix effects. Record
the absorbance at 318 nm. The absorbance is proportional to the sample 
concentration and can be determined from the calibration curve for 
"vanadium compounds" if the graphite tube in use gives reproducible 
results.
(1) Analysis for "metallic vanadium": Follow the procedure
described in step (k) using the following furnace parameters: dry at 100 C
for 20 seconds; char at 1100 C for 20 seconds, and atomize at 2,600 C for 8 
seconds. From the measured absorbance, determine the sample concentration 
using the calibration curve for "metallic vanadium".
Note: The characteristics of the graphite tubes can influence the
results significantly. Careful attention must be paid to the response of 
the standard, ie, if the graphite tube gives erratic results and a 
nonreproducible absorbance peak, it must be rejected and replaced because 
results obtained thereby are not reliable. Also, follow instrument 
manufacturer's recommendations for specific operating parameters.
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If a calibration curve cannot be used because of the changing 
characteristics of the graphite tube, it is recommended that samples be 
frequently alternated with standards which give responses close to that of 
the sample. The experimental protocol recommended is as follows: (1)
inject a standard solution in duplicate, (2) inject a sample in triplicate, 
and (3) reinject standard in duplicate, etc.
Appropriate filter blanks must be analyzed by the same procedure used 
for the samples.
Sample Recovery
To eliminate any bias in the analytical method, It is necessary to 
determine the recovery of the compound. The sample recovery should be 
determined in duplicate and should cover the concentration ranges of 
interest. If the recovery is less than 95%, the appropriate correction 
factor should be used to calculate the "true" value. Sample recovery must 
be studied for both "vanadium compounds" and "metallic vanadium."
(a) Add a portion of a standard solution containing a known 
amount of vanadium, preferably equivalent to the sample concentration 
expected, to a representative membrane filter and air dry. Recover the 
vanadium from the filter and analyze as described above. Duplicate 
determinations should agree within ± 5%.
(b) The sample recovery equals the average weight of 
vanadium in u %  recovered from the filter divided by the weight of vanadium 
in jug added to the filter, or:
recovery = average weight ( u g) recovered 
weight ( ju g )  added
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Calibration and Standards
Analysis of "vanadium compounds": From the standard "vanadium
compounds" working stock solution, prepare at least six calibration
standards to cover the vanadium concentration range from 0.1 to 1.0 jug/ml.
Prepare these calibration standards fresh daily and make all dilutions with
0.01 N sodium hydroxide. Proceed as in Analytical Procedure.
Analysis of "metallic vanadium": From the "metallic vanadium"
standard working stock solution, prepare at least six calibration standards 
to cover the vanadium concentration range from 0.1 to 1.0 jug/ml. Prepare 
these calibration standards fresh daily, and make all dilutions with 1%
(v/v) nitric acid. Proceed as in Analytical Procedure.
Prepare a calibration curve by plotting on linear graph paper the 
absorbance versus the vanadium concentration of each standard in /¿g/ml. It 
is advisable to run a set of standards both before and after the analysis 
of a series of samples to ensure that conditions have not changed.
In cases where a calibration curve could not be used reliably,
determine the appropriate response factor. To determine the response
factor, the appropriate calibration standards are alternately analyzed with 
the samples. This practice will minimize the effect of observed
fluctuations or variations in absorbance and peak height readings during 
any given day.
Calculations
(a) Read the vanadium concentration in jug/ml corresponding to the 
total absorbance from the standard curve. Or, alternatively, determine the 
vanadium concentration in jug/ml corresponding to the absorbance area of the
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sample by using the appropriate response factor determined from the
response of the calibration standard.
Make corrections for the blank by subtracting the amounts of 
vanadium found in the blank from the amounts found in the sample:
corrected i i g / r a l  = Mg/ml sample - n g / m l  blank
(b) Multiply the corrected Mg/ml by the sample volume of the
liquid sample (10 ml or 25 ml) to obtain the total weight of vanadium in 
the sample.
(c) Divide the total weight by the recovery to obtain the
corrected Mg/sample:
corrected jug/sample = total weight
recovery
(d) The concentration of vanadium in the air sampled can be
expressed in mg/cu m  (jug/liter = mg/cu m) .
mg/cu m = ___________corrected jug__________
volume of air sampled (liters)
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X I . APPENDIX III 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material shall be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation is inserted in the block in the upper left 
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the rules in Chapter V, 
Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The 
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially 
formal chemical nomenclature. Every known chemical designation or
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competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed in Section II shall be those substances which 
are part of the hazardous product covered by the MSDS and individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a
single component product must have the name of the material repeated in
this section to avoid giving the impression that there are no hazardous 
ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The may be the approximate percentage by weight or volume
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, ie, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the 
American National Standards Institute Inc. Flashpoint, shock sensitivity
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or similar descriptive data may be used to indicate flammability, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data in Section III should be for the total mixture and should 
include the boiling point and melting point in degrees Fahrenheit (Celsius 
in parentheses); vapor pressure, in conventional millimeters of mercury
(mmHg); vapor density of gas or vapor (air = 1); solubility in water, in
parts/hundred parts of water by weight; specific gravity (water ■ 1);
percent volatiles (indicated if by weight or volume) at 70 degrees 
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
sublimable solids, relative to butyl acetate; and appearance and odor. 
These data are useful for the control of toxic substances. Boiling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill 
containment equipment. The appearance and odor may facilitate
identification of substances stored in improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, including flashpoint and autoignition temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information. If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line 
labeled "Extinguishing Media."
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(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable 
standard. Other data are acceptable, such as lowest LD50 if multiple 
components are involved.
Under "Routes of Exposure," comments in each category should reflect
the potential hazard from absorption by the route in question. Comments
should indicate the severity of the effect and the basis for the statement
if possible. The basis might be animal studies, analogy with similar
products, or human experiences. Comments such as "yes" or "possible" are
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, possibly mild irritation.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed employees.
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(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances, such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect employees assigned to 
cleanup detail. Specific neutralizing chemicals or procedures should be 
described in detail. Disposal methods should be explicit including proper 
labeling of containers holding residues and ultimate disposal methods such 
as "sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures shall be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific information. Statements such as 
"Yes," "No," or "If necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. 
Respirators shall be specified as to type and NIOSH or US Bureau of Hines 
approval class, ie, "Supplied air," "Organic vapor canister," etc. 
Protective equipment must be specified as to type and materials of 
construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional information on 
any aspect of safety or health not covered in other sections should be 
inserted in Section IX. The lower block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and identify a source of additional information.
The MSDS shall be filed in a location readily accessible to employees 
exposed to the hazardous substance. The MSDS can be used as a training aid 
and basis for discussion during safety meetings and training of new 
employees. It should assist management by directing attention to the need 
for specific control engineering, work practices, and protective measures 
to ensure safe handling and use of the material. It will aid the safety 
and health staff in planning a safe and healthful work environment and in 
suggesting appropriate emergency procedures and sources of help in the 
event of harmful exposure of employees.
135
MATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M A N U F A C T U R E R  S  N A M E
R E G U L A R  T E L E P H O N E  NO. 
E M E R G E N C Y  T E L E P H O N E  N O




M A T E R I A L  O R  C O M P O N E N T % H A Z A R D  D A T A
III PHYSICAL DATA
B O I L I N G  P O IN T .  760  M M  HG M E L T I N G  P O IN T
S P E C I F I C  G R A V I T Y  ( H j O - l ) V A P O R  P R E S S U R E
V A P O R  D E N S I T Y  (A I R  = 1) S O L U B I L I T Y  IN  H 20 ,  % B Y  WT
%  V O L A T I L E S  B Y  V O L E V A P O R A T I O N  R A T E  ( B U T Y L  A C E T A T E  -1 i
A P P E A R A N C E  A N D  O D O R
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IV FIRE AND EXPLOSION DATA
f l a s h  p o i n t
(T EST  M E T H O D !
A U T O I G N I T IO N
T E M P E R A T U R E
f l a m m a b l e  l i m i t s  i n  a i r ,  % b y  v o l . L O W E R U P P E R
E X T I N G U I S H I N G
M E D I A
S P E C I A L  F IR E
F IG H T IN G
P R O C E D U R E S
U N U S U A L  F IR E  
A N D  E X P L O S I O N  
H A Z A R D
V HEALTH HAZARD INFORMATION
H E A L T H  H A Z A R D  D A T A
R O U T E S  O F  E X P O S U R E  
IN H A L A T I O N
S K I N  C O N T A C T
S K I N  A B S O R P T I O N
E V E  C O N T A C T
IN G E S T IO N
E F F E C T S  OF  O V E R E X P O S U R E  
A C U T E  O V E R E X P O S U R E
C H R O N I C  O V E R E X P O S U R E
E M E R G E N C Y  A N D  F IR S T  A I D  P R O C E D U R E S  
E V E S
S K I N
I N H A L A T I O N
IN G E S T  ION
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TABLE X I I -1
PH YSIC AL  A N D  C H E M IC A L  PRO PERT IES  OF V A N A D IU M  A N D  ITS COMPOUNDS














So lub ility  in g/100 cc
Cold  H 2 0 H ot H 2 0 Other Solvents
Vanadium V 50.942 0 5.96 1,890±10 3,380 Incot Insol So l in aqua regia, H N 0 3 , H 2S 0 4 , H F; 
insol in HCI, alkaline
Vanadium  carbide V C 62.95 4 5.77 2,810 3,900 ---- Sol in H N 0 3 , fused K N 0 3 ; insol in 
HCI, H 2S 0 4
Vanadium  tetrachloride vci4 192.75 4 1.81630 -28±2 148.5755 Sol, decom poses ---- Sol in absolute alcohol, ether, chloroform , 
acetic acid
Vanadium  trichloride V C I3 157.30 3 3.00 decomposes ------- Sol, decomposes So l in absolute alcohol, ether
Vanadyl sulfate voso4 163.00 4 ----- — ---- V ary  sol —
Iron metavanadate F e (V 0 3 )3 352.67 5 ---- — ---- Insol — So l in acid; insol in alcohol
Am m on ium  metavanadate n h 4 ( v o 3 ) 116.98 5 2.326 decom poses 200 ----- 0 .5 2 16 6.95,^®decomposes
Sod ium  metavanadate N a V O g 121.93 5 ----- 630 ------ 2 1 .1 25 38.875
Vanadium  oxide V O (o r  V 20 2 ) 66.94 2 5 .7 5 8 14 ignites ---- Insol Insol So l in acid
Vanadium  dioxide 
(or tetroxide)
vo2
(or V 20 4 )
82.94 4 4.339 1,967 ---- Sol in acid, alkali
Vanadium  pentoxide v 2 o 5 181.88 5 3 .3 5 7 18 690 decomposes 1,750
0<N00© ---- Sol in acid, alkali; insol in absolute alcohol
Vanadium  sesquioxide 
(or trioxide)
v2o3 149.88 3 18 4.87 4 1,970 — Slightly sol Sol So l in H N O g , H F , alkali
Vanadium  oxydichloride V O C I 2 137.85 4 2 .88*3 ----- — Decom poses ----- Sol in dilute H N 0 3
Vanadium  oxytrichloride voci3 173.30 5 1.829 -77±2 126.7 S o l , decomposes ----- Sol in alcohol, ether, acetic acid





Petroleum refinery workers 
Photographic chemical workers 
Textile dye workers 
Uranium millers 




Adapted from Gafafer [3]
TABLE XII-2
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